Signal	O
thresholds	O
and	O
modular	O
synergy	O
during	O
expression	O
of	O
costimulatory	O
molecules	O
in	O
B	B-cell_type
lymphocytes	I-cell_type
.	O

We	O
analyzed	O
intracellular	O
pathways	O
modulating	O
surface	O
densities	O
of	O
CD80	B-protein
and	O
CD86	B-protein
in	O
B	B-cell_type
cells	I-cell_type
activated	O
through	O
ligation	O
of	O
the	O
Ag	B-protein
receptor	I-protein
,	O
and	O
the	O
adhesion	B-protein
molecule	I-protein
CD54	B-protein
.	O

Whereas	O
B	B-protein
cell	I-protein
Ag	I-protein
receptor	I-protein
(	O
BCR	B-protein
)	O
cross-linking	O
alone	O
stimulated	O
increased	O
expression	O
of	O
CD86	B-protein
,	O
up-regulation	O
of	O
CD80	B-protein
required	O
dual	O
stimulation	O
with	O
anti-IgM	B-protein
and	O
anti-CD54	B-protein
.	O

The	O
principal	O
downstream	O
component	O
contributed	O
by	O
BCR	B-protein
signaling	O
,	O
toward	O
both	O
CD80	B-protein
and	O
CD86	B-protein
induction	O
,	O
was	O
the	O
elevated	O
concentration	O
of	O
free	O
cytoplasmic	O
Ca	O
(	O
2+	O
)	O
,	O
recruited	O
by	O
way	O
of	O
capacitative	O
influx	O
.	O

This	O
alone	O
was	O
sufficient	O
to	O
generate	O
an	O
increase	O
in	O
CD86	B-protein
levels	O
.	O

However	O
,	O
CD80	B-protein
enhancement	O
required	O
the	O
concerted	O
action	O
of	O
both	O
intracellular	O
Ca	O
(	O
2+	O
)	O
concentration	O
and	O
CD54-initiated	O
pathways	O
.	O

The	O
nexus	O
between	O
anti-IgM	O
and	O
anti-CD54	O
stimulation	O
,	O
in	O
the	O
context	O
of	O
CD80	B-protein
regulation	O
,	O
was	O
identified	O
to	O
involve	O
a	O
self-propagating	O
process	O
of	O
sequential	O
synergy	O
.	O

The	O
first	O
step	O
involved	O
amplified	O
accumulation	O
of	O
intracellular	O
cAMP	O
,	O
as	O
a	O
result	O
of	O
cross-talk	O
between	O
BCR	B-protein
-mobilized	O
Ca	O
(	O
2+	O
)	O
and	O
CD54-derived	O
signals	O
.	O

This	O
then	O
facilitated	O
a	O
second	O
synergistic	O
interaction	O
between	O
Ca	O
(	O
2+	O
)	O
and	O
cAMP	O
,	O
culminating	O
in	O
CD80	B-protein
expression	O
.	O

Our	O
findings	O
of	O
distinct	O
signal	O
transducer	O
requirements	O
,	O
with	O
the	O
added	O
consequences	O
of	O
cross-talk	O
,	O
offers	O
an	O
explanation	O
for	O
variable	O
modulation	O
of	O
costimulatory	O
molecule	O
expression	O
in	O
response	O
to	O
diverse	O
physiological	O
stimuli	O
.	O

Importantly	O
,	O
these	O
results	O
also	O
reveal	O
how	O
concentration	O
threshold	O
barriers	O
for	O
recruitment	O
of	O
individual	O
second	O
messengers	O
can	O
be	O
overcome	O
by	O
constructive	O
convergence	O
of	O
signaling	O
modules	O
.	O

o	NULL
~	NULL
Flexible	NULL
,	NULL
Intuitive	NULL
,	NULL
and	NULL
Luminex	NULL
.	NULL

C	NULL
,	NULL
$	NULL
3	NULL
Affordable	NULL
Cytometry	NULL
.	NULL

|	NULL
sarnmore	NULL
:	NULL
complexity	NULL
simplified	NULL
.	NULL

Guava®	NULL
easyCyte	NULL
``	NULL
Flow	NULL
Cytometers	NULL
.	NULL

meJournal	NULL
f	NULL
Signal	NULL
Thresholds	NULL
and	NULL
Modular	NULL
Synergy	NULL
During	NULL
Expression	NULL
of	NULL
Costimulatory	NULL
ImmunOIOgy	NULL
Molecules	NULL
in	NULL
B	NULL
Lymphocytes	NULL
This	NULL
information	NULL
is	NULL
current	NULL
as	NULL
__	NULL
Krishnamurthy	NULL
Natarajan	NULL
,	NULL
Naresh	NULL
C.	NULL
Sahoo	NULL
and	NULL
Kanury	NULL
V.	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

S.	NULL
Rao	NULL
J	NULL
Immunol	NULL
2001	NULL
;	NULL
167:114-122	NULL
;	NULL
;	NULL
doi	NULL
:	NULL
10.4049/jimmunol.167.1.114	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/167/1/114	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
45	NULL
articles	NULL
,	NULL
21	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/167/1/114.full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
Signal	NULL
Thresholds	NULL
and	NULL
Modular	NULL
Synergy	NULL
During	NULL
Expression	NULL
of	NULL
Costimulatory	NULL
Molecules	NULL
in	NULL
B	NULL
Lymphocytes	NULL
Krishnamurthy	NULL
Natarajan	NULL
,	NULL
Naresh	NULL
C.	NULL
Sahoo	NULL
,	NULL
and	NULL
Kanury	NULL
V.	NULL
S.	NULL
Rao	NULL
!	NULL

We	NULL
analyzed	NULL
intracellular	NULL
pathways	NULL
modulating	NULL
surface	NULL
densities	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
in	NULL
B	NULL
cells	NULL
activated	NULL
through	NULL
ligation	NULL
of	NULL
the	NULL
Ag	NULL
receptor	NULL
,	NULL
and	NULL
the	NULL
adhesion	NULL
molecule	NULL
CD54	NULL
.	NULL

Whereas	NULL
B	NULL
cell	NULL
Ag	NULL
receptor	NULL
(	NULL
BCR	NULL
)	NULL
cross-linking	NULL
alone	NULL
stimulated	NULL
increased	NULL
expression	NULL
of	NULL
CD86	NULL
,	NULL
up-regulation	NULL
of	NULL
CD80	NULL
required	NULL
dual	NULL
stimulation	NULL
with	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
.	NULL

The	NULL
principal	NULL
downstream	NULL
component	NULL
contributed	NULL
by	NULL
BCR	NULL
signaling	NULL
,	NULL
toward	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
induction	NULL
,	NULL
was	NULL
the	NULL
elevated	NULL
concentration	NULL
of	NULL
free	NULL
cytoplasmic	NULL
Ca*~	NULL
,	NULL
recruited	NULL
by	NULL
way	NULL
of	NULL
capacitative	NULL
influx	NULL
.	NULL

This	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
generate	NULL
an	NULL
increase	NULL
in	NULL
CD86	NULL
levels	NULL
.	NULL

However	NULL
,	NULL
CD80	NULL
enhancement	NULL
required	NULL
the	NULL
concerted	NULL
action	NULL
of	NULL
both	NULL
intracellular	NULL
Ca**	NULL
concentration	NULL
and	NULL
CDS4-initiated	NULL
pathways	NULL
.	NULL

The	NULL
nexus	NULL
between	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
stimulation	NULL
,	NULL
in	NULL
the	NULL
context	NULL
of	NULL
CD80	NULL
regulation	NULL
,	NULL
was	NULL
identified	NULL
to	NULL
involve	NULL
a	NULL
self-propagating	NULL
process	NULL
of	NULL
sequential	NULL
synergy	NULL
.	NULL

The	NULL
first	NULL
step	NULL
involved	NULL
amplified	NULL
accumulation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
,	NULL
as	NULL
a	NULL
result	NULL
of	NULL
cross-talk	NULL
between	NULL
BCR-mobilized	NULL
Ca**	NULL
and	NULL
CD54-derived	NULL
signals	NULL
.	NULL

This	NULL
then	NULL
facilitated	NULL
a	NULL
second	NULL
synergistic	NULL
interaction	NULL
between	NULL
Ca**	NULL
and	NULL
cAMP	NULL
,	NULL
culminating	NULL
in	NULL
CD80	NULL
expression	NULL
.	NULL

Our	NULL
findings	NULL
of	NULL
distinct	NULL
signal	NULL
transducer	NULL
requirements	NULL
,	NULL
with	NULL
the	NULL
added	NULL
consequences	NULL
of	NULL
cross-talk	NULL
,	NULL
offers	NULL
an	NULL
explanation	NULL
for	NULL
variable	NULL
modulation	NULL
of	NULL
costimulatory	NULL
molecule	NULL
expression	NULL
in	NULL
response	NULL
to	NULL
diverse	NULL
physiological	NULL
stimuli	NULL
.	NULL

Importantly	NULL
,	NULL
these	NULL
results	NULL
also	NULL
reveal	NULL
how	NULL
concentration	NULL
threshold	NULL
barriers	NULL
for	NULL
recruitment	NULL
of	NULL
individual	NULL
second	NULL
messen-	NULL
gers	NULL
can	NULL
be	NULL
overcome	NULL
by	NULL
constructive	NULL
convergence	NULL
of	NULL
signaling	NULL
modules	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
2001	NULL
,	NULL
167	NULL
:	NULL
114-122.	NULL
tailed	NULL
both	NULL
the	NULL
initiation	NULL
and	NULL
propagation	NULL
of	NULL
protein	NULL
phos-	NULL
phorylation	NULL
cascades	NULL
that	NULL
emanate	NULL
upon	NULL
ligation	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
Ag	NULL
receptor	NULL
(	NULL
BCR	NULL
)	NULL
``	NULL
(	NULL
1-6	NULL
)	NULL
.	NULL

This	NULL
process	NULL
is	NULL
initiated	NULL
by	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
immunoreceptor	NULL
tyrosine-based	NULL
activation	NULL
motif	NULL
(	NULL
ITAM	NULL
)	NULL
sequences	NULL
within	NULL
Iga	NULL
and	NULL
IgB	NULL
by	NULL
the	NULL
src	NULL
family	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
of	NULL
this	NULL
,	NULL
at	NULL
least	NULL
three	NULL
major	NULL
pathways	NULL
are	NULL
recruited	NULL
.	NULL

These	NULL
include	NULL
pathways	NULL
that	NULL
are	NULL
dependent	NULL
upon	NULL
phospholipase	NULL
Cy	NULL
,	NULL
the	NULL
Rho	NULL
family	NULL
of	NULL
GT-Pases	NULL
,	NULL
or	NULL
the	NULL
Ras/phosphatidylinositol-3-kinase	NULL
(	NULL
4-6	NULL
)	NULL
.	NULL

Although	NULL
much	NULL
of	NULL
the	NULL
current	NULL
emphasis	NULL
of	NULL
research	NULL
on	NULL
signal	NULL
transduction	NULL
in	NULL
lymphocytes	NULL
has	NULL
focused	NULL
on	NULL
the	NULL
initial	NULL
events	NULL
that	NULL
follow	NULL
receptor	NULL
triggering	NULL
,	NULL
the	NULL
various	NULL
downstream	NULL
mechanisms	NULL
that	NULL
eventually	NULL
culminate	NULL
into	NULL
modification	NULL
of	NULL
lymphocyte	NULL
function	NULL
remain	NULL
unknown	NULL
.	NULL

One	NULL
important	NULL
consequence	NULL
of	NULL
BCR	NULL
ligation	NULL
is	NULL
the	NULL
regulated	NULL
expression	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
surface	NULL
molecules	NULL
such	NULL
as	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
,	NULL
costimulatory	NULL
,	NULL
and	NULL
adhesion	NULL
molecules	NULL
(	NULL
7-11	NULL
)	NULL
.	NULL

It	NULL
is	NULL
the	NULL
cumulative	NULL
phenotypic	NULL
composition	NULL
of	NULL
the	NULL
surface	NULL
that	NULL
then	NULL
defines	NULL
functional	NULL
properties	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
,	NULL
either	NULL
in	NULL
terms	NULL
of	NULL
its	NULL
Ag	NULL
presenting	NULL
or	NULL
migratory	NULL
capabilities	NULL
(	NULL
10	NULL
,	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

Although	NULL
BCR	NULL
cross-linking	NULL
constitutes	NULL
the	NULL
principal	NULL
trigger	NULL
that	NULL
initiates	NULL
activation	NULL
of	NULL
B	NULL
cells	NULL
and	NULL
their	NULL
induction	NULL
into	NULL
a	NULL
response	NULL
,	NULL
it	NULL
is	NULL
now	NULL
be	NULL
I	NULL
:	NULL
xtensive	NULL
studies	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
laboratories	NULL
have	NULL
de	NULL
Immunology	NULL
Group	NULL
,	NULL
International	NULL
Centre	NULL
for	NULL
Genetic	NULL
Engineering	NULL
and	NULL
Biotechnology	NULL
,	NULL
Aruna	NULL
Asaf	NULL
Ali	NULL
Marg	NULL
,	NULL
New	NULL
Delhi	NULL
,	NULL
India	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
8	NULL
,	NULL
2001	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
April	NULL
23	NULL
,	NULL
2001	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Kanury	NULL
V.	NULL
S.	NULL
Rao	NULL
,	NULL
Immunology	NULL
Group	NULL
,	NULL
International	NULL
Center	NULL
for	NULL
Genetic	NULL
Engineering	NULL
and	NULL
Biotechnology	NULL
,	NULL
Aruna	NULL
Asaf	NULL
Ali	NULL
Marg	NULL
,	NULL
New	NULL
Delhi	NULL
110	NULL
067	NULL
,	NULL
India	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
kanury	NULL
@	NULL
icgeb.res.in	NULL
?	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
BCR	NULL
,	NULL
B	NULL
cell	NULL
Ag	NULL
receptor	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
PKA	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
;	NULL
db-cAMP	NULL
,	NULL
dibutyryl	NULL
cAMP	NULL
;	NULL
TMB-8	NULL
,	NULL
8-	NULL
(	NULL
diethylamino	NULL
)	NULL
octyl-3.4,5-trimethoxybenzoate	NULL
;	NULL
-	NULL
H89	NULL
,	NULL
-	NULL
N-	NULL
[	NULL
2-	NULL
(	NULL
(	NULL
p-bromocinamyl	NULL
)	NULL
amino	NULL
)	NULL
ethy	NULL
]	NULL
]	NULL
-5-isoquino-linesulfonamide	NULL
;	NULL
KN-62	NULL
,	NULL
1-	NULL
[	NULL
N	NULL
,	NULL
O-bis-	NULL
(	NULL
5-isoquinolinesulfony1	NULL
)	NULL
N-methyl-L-tyrosy1	NULL
]	NULL
-4-phenylpiperazine	NULL
;	NULL
|	NULL
fluo-3-AM	NULL
,	NULL
-	NULL
fluo-3-acetoxymethyl	NULL
ester	NULL
;	NULL
Ca	NULL
;	NULL
*	NULL
,	NULL
intracellular	NULL
calcium	NULL
ion	NULL
.	NULL

Copyright	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
coming	NULL
clear	NULL
that	NULL
this	NULL
effect	NULL
can	NULL
be	NULL
modulated	NULL
by	NULL
signals	NULL
generated	NULL
from	NULL
other	NULL
molecules	NULL
on	NULL
the	NULL
cell	NULL
surface	NULL
(	NULL
14	NULL
)	NULL
.	NULL

For	NULL
example	NULL
,	NULL
whereas	NULL
coligation	NULL
of	NULL
BCR	NULL
with	NULL
the	NULL
CR2/CD19/TAP-1	NULL
complex	NULL
leads	NULL
to	NULL
increased	NULL
B	NULL
cell	NULL
proliferation	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
cross-linking	NULL
of	NULL
BCR	NULL
with	NULL
the	NULL
FeyRIIb	NULL
coreceptor	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
inhibitory	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
reciprocal	NULL
desensitization	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
and	NULL
BCR	NULL
signaling	NULL
has	NULL
also	NULL
been	NULL
recently	NULL
demonstrated	NULL
(	NULL
21	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
while	NULL
the	NULL
regulatory	NULL
influences	NULL
of	NULL
cell	NULL
surface	NULL
accessory	NULL
molecules	NULL
on	NULL
BCR	NULL
signaling	NULL
is	NULL
being	NULL
increasingly	NULL
recognized	NULL
,	NULL
the	NULL
mechanisms	NULL
through	NULL
which	NULL
independently	NULL
generated	NULL
biochemical	NULL
pathways	NULL
interface	NULL
and	NULL
,	NULL
thereby	NULL
,	NULL
modulate	NULL
cell	NULL
function	NULL
remains	NULL
poorly	NULL
understood	NULL
.	NULL

To	NULL
gain	NULL
further	NULL
insights	NULL
into	NULL
this	NULL
aspect	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
induction	NULL
of	NULL
CD80	NULL
(	NULL
B7-1	NULL
)	NULL
and	NULL
CD86	NULL
(	NULL
B7-2	NULL
)	NULL
in	NULL
splenic	NULL
B	NULL
cells	NULL
under	NULL
a	NULL
defined	NULL
set	NULL
of	NULL
conditions	NULL
.	NULL

As	NULL
shown	NULL
earlier	NULL
by	NULL
us	NULL
(	NULL
22	NULL
)	NULL
and	NULL
others	NULL
(	NULL
10	NULL
)	NULL
,	NULL
moderate	NULL
cross-linking	NULL
of	NULL
the	NULL
BCR	NULL
was	NULL
sufficient	NULL
to	NULL
enhance	NULL
surface	NULL
levels	NULL
of	NULL
CD86	NULL
but	NULL
not	NULL
CD80	NULL
.	NULL

The	NULL
latter	NULL
required	NULL
provision	NULL
of	NULL
an	NULL
additional	NULL
stimulus	NULL
either	NULL
in	NULL
the	NULL
form	NULL
of	NULL
a	NULL
cytokine	NULL
or	NULL
ligation	NULL
of	NULL
a	NULL
second	NULL
molecule	NULL
on	NULL
the	NULL
B	NULL
cell	NULL
surface	NULL
(	NULL
22-24	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
additional	NULL
stimulus	NULL
used	NULL
was	NULL
anti-CD54	NULL
(	NULL
ICAM-1	NULL
)	NULL
which	NULL
,	NULL
in	NULL
conjunction	NULL
with	NULL
anti-IgM	NULL
treat-ment	NULL
,	NULL
led	NULL
to	NULL
a	NULL
marked	NULL
enhancement	NULL
in	NULL
CD80	NULL
levels	NULL
.	NULL

Using	NULL
such	NULL
a	NULL
system	NULL
,	NULL
we	NULL
demonstrate	NULL
how	NULL
distinctions	NULL
in	NULL
both	NULL
the	NULL
concentration	NULL
and	NULL
spectrum	NULL
of	NULL
key	NULL
second	NULL
messenger	NULL
intermediates	NULL
can	NULL
account	NULL
for	NULL
the	NULL
distinct	NULL
induction	NULL
thresholds	NULL
of	NULL
these	NULL
two	NULL
molecules	NULL
.	NULL

Furthermore	NULL
,	NULL
our	NULL
data	NULL
also	NULL
reveal	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
novel	NULL
process	NULL
of	NULL
sequential	NULL
synergy	NULL
that	NULL
is	NULL
involved	NULL
during	NULL
CD80	NULL
up-regulation	NULL
.	NULL

Finally	NULL
,	NULL
present	NULL
findings	NULL
also	NULL
provide	NULL
a	NULL
preliminary	NULL
insight	NULL
into	NULL
how	NULL
B	NULL
cell	NULL
responsiveness-at	NULL
least	NULL
in	NULL
the	NULL
context	NULL
of	NULL
costimulatory	NULL
molecule	NULL
expression-	NULL
can	NULL
be	NULL
variably	NULL
modulated	NULL
by	NULL
diverse	NULL
physiological	NULL
stimuli	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
mAbs	NULL
against	NULL
mouse	NULL
molecules	NULL
CD80	NULL
(	NULL
clone	NULL
1G10	NULL
)	NULL
,	NULL
CD86	NULL
(	NULL
clone	NULL
GL-1	NULL
)	NULL
,	NULL
CD54	NULL
(	NULL
clone	NULL
3E2	NULL
)	NULL
,	NULL
B220	NULL
(	NULL
clone	NULL
RA3-6B2	NULL
)	NULL
,	NULL
and	NULL
isotype-matched	NULL
controls	NULL
were	NULL
obtained	NULL
from	NULL
BD	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Goat	NULL
anti-mouse	NULL
IgM	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Ab-coated	NULL
magnetic	NULL
0022-1767/01/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
beads	NULL
for	NULL
the	NULL
purification	NULL
of	NULL
B	NULL
lymphocytes	NULL
were	NULL
obtained	NULL
from	NULL
Miltenyi	NULL
Biotec	NULL
(	NULL
Auburn	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Inhibitors	NULL
to	NULL
various	NULL
kinases	NULL
such	NULL
as	NULL
genistein	NULL
,	NULL
calphostin	NULL
C	NULL
,	NULL
1-	NULL
[	NULL
N	NULL
,	NULL
O-bis-	NULL
(	NULL
5-isoquinolinesulfony1	NULL
)	NULL
N-methyl-L-tyrosy1	NULL
]	NULL
-4-phe-nylpiperazine	NULL
(	NULL
KN-62	NULL
)	NULL
,	NULL
calmidazolium	NULL
,	NULL
cyclosporin	NULL
A	NULL
,	NULL
EGTA	NULL
,	NULL
and	NULL
other	NULL
reagents	NULL
such	NULL
as	NULL
guanidine	NULL
isothiocyanate	NULL
and	NULL
dibutyryl-cAMP	NULL
(	NULL
db-cAMP	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Ionomycin	NULL
,	NULL
8-	NULL
(	NULL
diethylamino	NULL
)	NULL
oc-tyl-3,4,5-trimethoxybenzoate	NULL
(	NULL
TMB-8	NULL
)	NULL
,	NULL
N-	NULL
[	NULL
2-	NULL
(	NULL
(	NULL
p-bromocinamyl	NULL
)	NULL
amin-o	NULL
)	NULL
ethyl	NULL
]	NULL
-5-isoquinolinesulfonamide	NULL
(	NULL
H89	NULL
)	NULL
,	NULL
fluo-3-acetoxymethyl	NULL
ester	NULL
(	NULL
fluo-3-AM	NULL
)	NULL
,	NULL
Abs	NULL
to	NULL
Ser'*	NULL
>	NULL
-phosphorylated	NULL
CREB	NULL
,	NULL
and	NULL
CREB	NULL
were	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Intracellular	NULL
cAMP	NULL
levels	NULL
were	NULL
measured	NULL
using	NULL
the	NULL
BIOTRAK	NULL
EIA	NULL
cAMP	NULL
detection	NULL
kit	NULL
from	NULL
Amersham	NULL
(	NULL
Ar-lington	NULL
Heights	NULL
,	NULL
IL	NULL
)	NULL
.	NULL

Primers	NULL
specific	NULL
for	NULL
the	NULL
B-actin	NULL
gene	NULL
were	NULL
obtained	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WD	NULL
)	NULL
.	NULL

In	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
Abs	NULL
were	NULL
used	NULL
as	NULL
their	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
,	NULL
fragments	NULL
,	NULL
which	NULL
were	NULL
obtained	NULL
by	NULL
digestion	NULL
with	NULL
pepsin	NULL
,	NULL
followed	NULL
by	NULL
purification	NULL
over	NULL
a	NULL
protein	NULL
G-Sepharose	NULL
column	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
25	NULL
)	NULL
.	NULL

Animals	NULL
Female	NULL
BALB/c	NULL
mice	NULL
(	NULL
6-8	NULL
wk	NULL
old	NULL
)	NULL
,	NULL
maintained	NULL
under	NULL
pathogen-free	NULL
con-ditions	NULL
,	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
small	NULL
experimental	NULL
facility	NULL
of	NULL
our	NULL
institute	NULL
.	NULL

Enrichment	NULL
of	NULL
B	NULL
lymphocytes	NULL
This	NULL
was	NULL
achieved	NULL
by	NULL
negative	NULL
selection	NULL
,	NULL
through	NULL
magnetic	NULL
sorting	NULL
,	NULL
essentially	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
splenocytes	NULL
from	NULL
6-	NULL
to	NULL
8-wk-old	NULL
BALB/c	NULL
mice	NULL
were	NULL
first	NULL
depleted	NULL
of	NULL
adherent	NULL
cells	NULL
by	NULL
panning	NULL
over	NULL
plastic	NULL
plates	NULL
.	NULL

From	NULL
this	NULL
,	NULL
T	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
two	NULL
rounds	NULL
of	NULL
incubation	NULL
with	NULL
a	NULL
mixture	NULL
of	NULL
magnetic	NULL
beads	NULL
individually	NULL
coated	NULL
with	NULL
anti-CD4	NULL
,	NULL
anti-CD8	NULL
,	NULL
and	NULL
anti-CD90	NULL
(	NULL
Thy	NULL
1.2	NULL
)	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
IgG*	NULL
population	NULL
was	NULL
also	NULL
removed	NULL
by	NULL
additional	NULL
incubation	NULL
of	NULL
cells	NULL
with	NULL
anti-mouse	NULL
IgG-coated	NULL
microbeads	NULL
.	NULL

Separation	NULL
was	NULL
achieved	NULL
using	NULL
MACS	NULL
columns	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
the	NULL
resulting	NULL
population	NULL
of	NULL
B	NULL
cells	NULL
obtained	NULL
in	NULL
this	NULL
fashion	NULL
was	NULL
95-98	NULL
%	NULL
when	NULL
measured	NULL
as	NULL
B220-PE-stained	NULL
cells	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Stimulation	NULL
of	NULL
B	NULL
cells	NULL
and	NULL
analyses	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
expression	NULL
by	NULL
flow	NULL
cytometry	NULL
Enriched	NULL
B	NULL
cells	NULL
were	NULL
plated	NULL
in	NULL
96-well	NULL
plates	NULL
at	NULL
3	NULL
X	NULL
10°/well	NULL
in	NULL
0.1	NULL
ml	NULL
of	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
antibiotics	NULL
(	NULL
RPMI	NULL
10	NULL
)	NULL
.	NULL

Depending	NULL
on	NULL
the	NULL
requirement	NULL
,	NULL
cells	NULL
were	NULL
cultured	NULL
with	NULL
the	NULL
F	NULL
(	NULL
ab	NULL
)	NULL
,	NULL
fragment	NULL
of	NULL
anti-IgM	NULL
(	NULL
10	NULL
ug/m1	NULL
)	NULL
,	NULL
and/or	NULL
anti-CD54	NULL
(	NULL
10	NULL
pg/ml	NULL
)	NULL
,	NULL
and/or	NULL
ionomycin	NULL
(	NULL
0.5	NULL
wM	NULL
)	NULL
.	NULL

In	NULL
initial	NULL
experiments	NULL
,	NULL
stimulation	NULL
times	NULL
were	NULL
varied	NULL
from	NULL
2	NULL
to	NULL
24	NULL
h	NULL
for	NULL
CD86	NULL
analysis	NULL
,	NULL
and	NULL
from	NULL
2	NULL
to	NULL
60	NULL
h	NULL
when	NULL
CD80	NULL
levels	NULL
were	NULL
being	NULL
monitored	NULL
.	NULL

Although	NULL
a	NULL
2-h	NULL
stimulation	NULL
time	NULL
with	NULL
anti-IgM	NULL
was	NULL
sufficient	NULL
to	NULL
induce	NULL
CD86	NULL
,	NULL
significant	NULL
CD80	NULL
up-regulation	NULL
required	NULL
between	NULL
8	NULL
and	NULL
12	NULL
h	NULL
of	NULL
treatment	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
.	NULL

Consequently	NULL
,	NULL
a	NULL
standard	NULL
stimulation	NULL
time	NULL
of	NULL
12	NULL
h	NULL
was	NULL
used	NULL
for	NULL
all	NULL
of	NULL
the	NULL
experiments	NULL
reported	NULL
here	NULL
.	NULL

For	NULL
the	NULL
effects	NULL
of	NULL
inhibitors	NULL
,	NULL
cells	NULL
were	NULL
pre-equilibrated	NULL
with	NULL
EGTA	NULL
(	NULL
3	NULL
mM	NULL
)	NULL
,	NULL
genistein	NULL
(	NULL
60	NULL
pg/ml	NULL
)	NULL
,	NULL
calphostin	NULL
C	NULL
(	NULL
0.1	NULL
uM	NULL
)	NULL
,	NULL
calmidazo-lium	NULL
(	NULL
20	NULL
nM	NULL
)	NULL
,	NULL
KN-62	NULL
(	NULL
5	NULL
uM	NULL
)	NULL
,	NULL
cyclosporin	NULL
A	NULL
(	NULL
8	NULL
M	NULL
)	NULL
,	NULL
or	NULL
H89	NULL
(	NULL
100	NULL
nM	NULL
)	NULL
for	NULL
1	NULL
h	NULL
before	NULL
addition	NULL
of	NULL
the	NULL
appropriate	NULL
stimuli	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
incubation	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
thoroughly	NULL
in	NULL
ice-cold	NULL
HBSS	NULL
to	NULL
remove	NULL
all	NULL
traces	NULL
of	NULL
excess	NULL
stimuli	NULL
and	NULL
inhibitors	NULL
,	NULL
and	NULL
cultured	NULL
again	NULL
in	NULL
complete	NULL
medium	NULL
(	NULL
RPMI	NULL
1640	NULL
containing	NULL
10	NULL
%	NULL
FCS	NULL
)	NULL
for	NULL
the	NULL
requisite	NULL
time	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
c	NULL
)	NULL
,	NULL
CD86	NULL
levels	NULL
were	NULL
measured	NULL
at	NULL
24	NULL
h	NULL
poststimulation	NULL
with	NULL
anti-IgM	NULL
or	NULL
ionomycin	NULL
,	NULL
whereas	NULL
CD80	NULL
was	NULL
measured	NULL
at	NULL
60	NULL
h	NULL
after	NULL
addition	NULL
of	NULL
the	NULL
appropriate	NULL
stimulants	NULL
.	NULL

The	NULL
viability	NULL
of	NULL
cells	NULL
was	NULL
at	NULL
least	NULL
95	NULL
%	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
ex-clusion	NULL
,	NULL
for	NULL
all	NULL
the	NULL
analyses	NULL
reported	NULL
here	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
the	NULL
requisite	NULL
culture	NULL
period	NULL
,	NULL
the	NULL
Fc	NULL
receptors	NULL
on	NULL
the	NULL
cells	NULL
were	NULL
blocked	NULL
with	NULL
anti-CD16/CD32	NULL
(	NULL
BD	NULL
PharMingen	NULL
)	NULL
before	NULL
analysis	NULL
.	NULL

Following	NULL
this	NULL
,	NULL
cells	NULL
were	NULL
stained	NULL
with	NULL
biotinylated	NULL
anti-B220	NULL
(	NULL
1	NULL
ug/10°	NULL
cells	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
)	NULL
and	NULL
then	NULL
labeled	NULL
with	NULL
streptavidin-PE	NULL
.	NULL

After	NULL
adequate	NULL
washes	NULL
(	NULL
PBS	NULL
with	NULL
0.5	NULL
%	NULL
BSA	NULL
and	NULL
0.01	NULL
%	NULL
azide	NULL
)	NULL
,	NULL
cells	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
second	NULL
round	NULL
of	NULL
staining	NULL
with	NULL
FITC-conjugated	NULL
Abs	NULL
against	NULL
either	NULL
CD80	NULL
or	NULL
CD86	NULL
(	NULL
1	NULL
ug/10®	NULL
cells	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
)	NULL
and	NULL
then	NULL
fixed	NULL
in	NULL
buffer	NULL
containing	NULL
0.1	NULL
%	NULL
paraformaldehyde	NULL
.	NULL

Two-color	NULL
analysis	NULL
was	NULL
conducted	NULL
on	NULL
a	NULL
FACSCalibur	NULL
flow	NULL
cytometer	NULL
(	NULL
BD	NULL
Immunocytometry	NULL
Systems	NULL
,	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Logarithmically	NULL
amplified	NULL
fluorescence	NULL
data	NULL
were	NULL
collected	NULL
on	NULL
5	NULL
X	NULL
10°	NULL
viable	NULL
cells	NULL
as	NULL
determined	NULL
by	NULL
forward	NULL
scatter	NULL
intensity	NULL
and	NULL
by	NULL
exclusion	NULL
of	NULL
propidium	NULL
io-dide-stained	NULL
cells	NULL
.	NULL

Quantitation	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
mRNA	NULL
levels	NULL
Total	NULL
cellular	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cultured	NULL
cells	NULL
at	NULL
the	NULL
time	NULL
point	NULL
indicated	NULL
in	NULL
figure	NULL
legends	NULL
using	NULL
guanidine	NULL
isothiocyanate	NULL
followed	NULL
by	NULL
acid	NULL
phenol	NULL
treatment	NULL
.	NULL

Total	NULL
RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
fractionated	NULL
on	NULL
a	NULL
formaldehyde	NULL
115	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
onto	NULL
Hybond-N	NULL
nylon	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
,	NULL
and	NULL
subsequently	NULL
probed	NULL
with	NULL
*°P-labeled	NULL
gene-specific	NULL
full-length	NULL
probes	NULL
for	NULL
CD80	NULL
and	NULL
CD86	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
exposed	NULL
to	NULL
x-ray	NULL
films	NULL
and	NULL
developed	NULL
later	NULL
.	NULL

Following	NULL
this	NULL
,	NULL
blots	NULL
were	NULL
stripped	NULL
off	NULL
the	NULL
initial	NULL
probe	NULL
and	NULL
then	NULL
hybridized	NULL
with	NULL
*°P-labeled	NULL
probes	NULL
for	NULL
B-actin	NULL
as	NULL
loading	NULL
controls	NULL
.	NULL

Monitoring	NULL
intracellular	NULL
Ca	NULL
``	NULL
levels	NULL
Enriched	NULL
B	NULL
cells	NULL
(	NULL
2	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
uM	NULL
fluo-3-AM	NULL
in	NULL
1	NULL
ml	NULL
of	NULL
culture	NULL
medium	NULL
for	NULL
45	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

Thereafter	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
thoroughly	NULL
in	NULL
HBSS	NULL
and	NULL
finally	NULL
resuspended	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
of	NULL
culture	NULL
medium	NULL
alone	NULL
or	NULL
in	NULL
medium	NULL
containing	NULL
either	NULL
3	NULL
mM	NULL
EGTA	NULL
or	NULL
50	NULL
M	NULL
TMB-8	NULL
.	NULL

After	NULL
a	NULL
15-min	NULL
incubation	NULL
at	NULL
room	NULL
temperature	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
appropriate	NULL
agents	NULL
and	NULL
the	NULL
resultant	NULL
variation	NULL
in	NULL
intracellular	NULL
Ca**	NULL
was	NULL
monitored	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Estimation	NULL
of	NULL
intracellular	NULL
levels	NULL
of	NULL
cAMP	NULL
Enriched	NULL
B	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
cultured	NULL
for	NULL
12	NULL
h	NULL
were	NULL
transferred	NULL
into	NULL
serum-free	NULL
medium	NULL
and	NULL
equilibrated	NULL
over	NULL
an	NULL
additional	NULL
4	NULL
h	NULL
of	NULL
culture	NULL
.	NULL

Following	NULL
this	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
serum-free	NULL
medium	NULL
at	NULL
1	NULL
X	NULL
10°	NULL
cells/ml	NULL
,	NULL
and	NULL
100-pl	NULL
aliquots	NULL
were	NULL
plated	NULL
into	NULL
wells	NULL
of	NULL
a	NULL
96-well	NULL
tissue	NULL
culture	NULL
plate	NULL
.	NULL

Quadruplicate	NULL
sets	NULL
of	NULL
wells	NULL
were	NULL
stimulated	NULL
with	NULL
the	NULL
appropriate	NULL
agent	NULL
(	NULL
or	NULL
mock-stimulated	NULL
with	NULL
carrier	NULL
only	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

The	NULL
resulting	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
were	NULL
then	NULL
measured	NULL
in	NULL
cell	NULL
lysates	NULL
using	NULL
the	NULL
BIOTRAK	NULL
EIA	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
strictly	NULL
following	NULL
the	NULL
protocol	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
effects	NULL
of	NULL
exogenous	NULL
addition	NULL
of	NULL
db-cAMP	NULL
on	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
,	NULL
cells	NULL
prepared	NULL
as	NULL
above	NULL
were	NULL
incubated	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
db-cAMP	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

Following	NULL
this	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
extensively	NULL
in	NULL
serum-free	NULL
medium	NULL
to	NULL
remove	NULL
any	NULL
traces	NULL
of	NULL
excess	NULL
db-cAMP	NULL
.	NULL

The	NULL
remaining	NULL
procedure	NULL
was	NULL
identical	NULL
with	NULL
that	NULL
described	NULL
above	NULL
.	NULL

Analysis	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
Enriched	NULL
B	NULL
cells	NULL
were	NULL
equilibrated	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
various	NULL
inhibitors	NULL
for	NULL
1	NULL
h	NULL
before	NULL
stimulation	NULL
with	NULL
the	NULL
appropriate	NULL
agents	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
this	NULL
the	NULL
cells	NULL
were	NULL
chilled	NULL
on	NULL
ice	NULL
,	NULL
washed	NULL
with	NULL
ice-cold	NULL
PBS	NULL
,	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
;	NULL
10	NULL
mM	NULL
KCI	NULL
;	NULL
0.1	NULL
mM	NULL
EDTA	NULL
;	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
and	NULL
2	NULL
mg/ml	NULL
each	NULL
of	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
nuclear	NULL
pellet	NULL
was	NULL
then	NULL
extracted	NULL
in	NULL
buffer	NULL
containing	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
7.9	NULL
)	NULL
;	NULL
0.4	NULL
M	NULL
NaCl	NULL
;	NULL
1	NULL
mM	NULL
EDTA	NULL
;	NULL
1	NULL
mM	NULL
EGTA	NULL
;	NULL
and	NULL
2	NULL
mg/ml	NULL
each	NULL
of	NULL
aprotinin	NULL
,	NULL
leupeptin	NULL
,	NULL
and	NULL
pepstatin	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
1	NULL
X	NULL
10	NULL
``	NULL
cells	NULL
were	NULL
each	NULL
resolved	NULL
on	NULL
10	NULL
%	NULL
SDS-polyacrylamide	NULL
gels	NULL
and	NULL
subsequently	NULL
transferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
membrane	NULL
(	NULL
Hybond	NULL
C*	NULL
;	NULL
Amersham	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
blots	NULL
were	NULL
probed	NULL
with	NULL
rabbit	NULL
Abs	NULL
specific	NULL
for	NULL
CREB	NULL
,	NULL
followed	NULL
by	NULL
HRP-labeled	NULL
secondary	NULL
Abs	NULL
.	NULL

Blots	NULL
were	NULL
developed	NULL
by	NULL
chemiluminescence	NULL
using	NULL
the	NULL
ECL	NULL
kit	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

To	NULL
verify	NULL
comparable	NULL
loading	NULL
of	NULL
proteins	NULL
,	NULL
bound	NULL
Abs	NULL
were	NULL
stripped	NULL
off	NULL
,	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
subjected	NULL
to	NULL
a	NULL
second	NULL
round	NULL
of	NULL
screening	NULL
with	NULL
anti-CREB	NULL
Abs	NULL
.	NULL

Results	NULL
BCR-dependent	NULL
induction	NULL
of	NULL
CD86	NULL
and	NULL
CD80	NULL
levels	NULL
in	NULL
B	NULL
cells	NULL
Stimulation	NULL
of	NULL
splenic	NULL
B	NULL
cells	NULL
with	NULL
anti-IgM	NULL
Abs	NULL
(	NULL
see	NULL
Material	NULL
and	NULL
Methods	NULL
)	NULL
induced	NULL
increased	NULL
surface	NULL
expression	NULL
of	NULL
CD86	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
although	NULL
no	NULL
concurrent	NULL
effect	NULL
on	NULL
CD80	NULL
was	NULL
noted	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
enhanced	NULL
surface	NULL
expression	NULL
of	NULL
CD80	NULL
could	NULL
readily	NULL
be	NULL
obtained	NULL
upon	NULL
dual	NULL
stimulation	NULL
of	NULL
cells	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
(	NULL
ICAM-1	NULL
)	NULL
Abs	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
b	NULL
)	NULL
.	NULL

Both	NULL
of	NULL
these	NULL
stimuli	NULL
were	NULL
found	NULL
to	NULL
be	NULL
obligatory	NULL
,	NULL
because	NULL
addition	NULL
of	NULL
either	NULL
component	NULL
alone	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
CD80	NULL
levels	NULL
.	NULL

This	NULL
contrasted	NULL
with	NULL
the	NULL
effect	NULL
on	NULL
CD86	NULL
,	NULL
where	NULL
stimulation	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
did	NULL
not	NULL
yield	NULL
any	NULL
significant	NULL
enhancement	NULL
in	NULL
levels	NULL
over	NULL
that	NULL
obtained	NULL
with	NULL
anti-IgM	NULL
stimulation	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
distinct	NULL
stimulus	NULL
requirements	NULL
,	NULL
the	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
these	NULL
two	NULL
molecules	NULL
also	NULL
differed	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
c.	NULL
When	NULL
compared	NULL
with	NULL
CD86	NULL
,	NULL
CD80	NULL
showed	NULL
delayed	NULL
induction	NULL
becoming	NULL
apparent	NULL
only	NULL
several	NULL
hours	NULL
after	NULL
initiation	NULL
of	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
,	NULL
c	NULL
)	NULL
.	NULL

This	NULL
observed	NULL
enhancement	NULL
in	NULL
surface	NULL
densities	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
in	NULL
response	NULL
to	NULL
the	NULL
appropriate	NULL
stimuli	NULL
also	NULL
correlated	NULL
well	NULL
with	NULL
a	NULL
concomitant	NULL
increase	NULL
in	NULL
the	NULL
respective	NULL
mRNA	NULL
levels	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
.	NULL

The	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
116	NULL
A	NULL
a	NULL
b	NULL
a	NULL
mi	NULL
c	NULL
\	NULL
9	NULL
h	NULL
S	NULL
El	NULL
!	NULL

2	NULL
3	NULL
5	NULL
J	NULL
.	NULL

‘	NULL
io	NULL
15	NULL
30	NULL
45	NULL
60	NULL
75	NULL
~	NULL
matting	NULL
Time	NULL
(	NULL
hrs	NULL
)	NULL
B	NULL
Q	NULL
anti-IgM	NULL
-	NULL
b	NULL
anti-lgM	NULL
-	NULL
+0	NULL
;	NULL
0	NULL
+	NULL
+	NULL
Gen	NULL
<	NULL
0	NULL
-	NULL
anti-CD54	NULL
t	NULL
=t	NULL
+	NULL
O+	NULL
O+	NULL
Gen	NULL
-	NULL
-	NULL
>	NULL
>	NULL
+	NULL
co	NULL
86	NULL
[	NULL
~	NULL
cp	NULL
80	NULL
~~	NULL
@	NULL
@	NULL
#	NULL
#	NULL
-e	NULL
Ge	NULL
~-	NULL
Mtb	NULL
FIGURE	NULL
1	NULL
.	NULL

Induction	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Cell	NULL
surface	NULL
staining	NULL
for	NULL
CD86	NULL
(	NULL
a	NULL
)	NULL
or	NULL
CD80	NULL
(	NULL
b	NULL
)	NULL
in	NULL
B220*	NULL
gated	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
left	NULL
unstimulated	NULL
(	NULL
thin	NULL
line	NULL
)	NULL
or	NULL
stimulated	NULL
(	NULL
thick	NULL
line	NULL
)	NULL
with	NULL
either	NULL
anti-IgM	NULL
(	NULL
a	NULL
)	NULL
or	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
(	NULL
b	NULL
)	NULL
.	NULL

A	NULL
parallel	NULL
set	NULL
of	NULL
cells	NULL
were	NULL
also	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
genistein	NULL
.	NULL

Although	NULL
the	NULL
results	NULL
for	NULL
CD80	NULL
are	NULL
shown	NULL
by	NULL
the	NULL
dashed	NULL
line	NULL
(	NULL
b	NULL
)	NULL
,	NULL
the	NULL
corresponding	NULL
profile	NULL
for	NULL
CD86	NULL
was	NULL
superimposable	NULL
over	NULL
that	NULL
obtained	NULL
for	NULL
unstimulated	NULL
cells	NULL
.	NULL

c	NULL
,	NULL
Kinetics	NULL
of	NULL
induction	NULL
of	NULL
CD86	NULL
(	NULL
0	NULL
)	NULL
and	NULL
CD80	NULL
(	NULL
@	NULL
)	NULL
in	NULL
appropriately	NULL
stimulated	NULL
cells	NULL
.	NULL

A	NULL
Northern	NULL
blot	NULL
analyses	NULL
,	NULL
using	NULL
cDNA	NULL
probes	NULL
,	NULL
for	NULL
the	NULL
corresponding	NULL
mRNA	NULL
species	NULL
is	NULL
also	NULL
shown	NULL
in	NULL
B	NULL
.	NULL

For	NULL
CD86	NULL
,	NULL
mRNA	NULL
extracts	NULL
were	NULL
prepared	NULL
at	NULL
24	NULL
h	NULL
after	NULL
initiation	NULL
of	NULL
stimulation	NULL
,	NULL
whereas	NULL
extracts	NULL
for	NULL
CD80	NULL
mRNA	NULL
analysis	NULL
were	NULL
prepared	NULL
48	NULL
h	NULL
later	NULL
.	NULL

Data	NULL
in	NULL
A	NULL
are	NULL
representative	NULL
of	NULL
at	NULL
least	NULL
five	NULL
separate	NULL
experiments	NULL
,	NULL
whereas	NULL
those	NULL
in	NULL
B	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

BActin	NULL
magnitude	NULL
of	NULL
increase	NULL
in	NULL
cellular	NULL
mRNA	NULL
content	NULL
observed	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
may	NULL
likely	NULL
reflect	NULL
increased	NULL
transcriptional	NULL
activation	NULL
of	NULL
genes	NULL
for	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
.	NULL

However	NULL
,	NULL
the	NULL
alternate	NULL
possibility	NULL
that	NULL
this	NULL
increase	NULL
derives	NULL
from	NULL
enhanced	NULL
message	NULL
stability	NULL
can	NULL
not	NULL
presently	NULL
be	NULL
ruled	NULL
out	NULL
.	NULL

Induction	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
in	NULL
response	NULL
to	NULL
the	NULL
appropriate	NULL
stimuli	NULL
could	NULL
be	NULL
inhibited	NULL
by	NULL
the	NULL
inclusion	NULL
of	NULL
genistein	NULL
,	NULL
a	NULL
broad	NULL
spectrum	NULL
inhibitor	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
26	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
was	NULL
exercised	NULL
at	NULL
the	NULL
level	NULL
of	NULL
cell	NULL
surface	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

14	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
at	NULL
that	NULL
of	NULL
the	NULL
respective	NULL
mRNAs	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

These	NULL
latter	NULL
results	NULL
imply	NULL
the	NULL
dependence	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
regulatory	NULL
pathways	NULL
on	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
events	NULL
initiated	NULL
upon	NULL
receptor	NULL
ligation	NULL
.	NULL

Intracellular	NULL
calcium	NULL
ion	NULL
(	NULL
Ca	NULL
``	NULL
)	NULL
concentrations	NULL
modulate	NULL
expression	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
To	NULL
dissect	NULL
biochemical	NULL
mediators	NULL
of	NULL
the	NULL
above	NULL
response	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
addition	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
pharmacological	NULL
inhibitors	NULL
.	NULL

In	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
addition	NULL
of	NULL
either	NULL
TMB-8	NULL
or	NULL
EGTA	NULL
completely	NULL
abolished	NULL
both	NULL
anti-IgM-dependent	NULL
CD86	NULL
up-regulation	NULL
and	NULL
CD80	NULL
up-regulation	NULL
mediated	NULL
by	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
.	NULL

Whereas	NULL
TMB-8	NULL
is	NULL
known	NULL
to	NULL
inhibit	NULL
Ca**	NULL
release	NULL
from	NULL
intracellular	NULL
stores	NULL
(	NULL
27	NULL
)	NULL
,	NULL
EGTA	NULL
blocks	NULL
its	NULL
influx	NULL
from	NULL
the	NULL
extracellular	NULL
milieu	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
inhibitory	NULL
effects	NULL
of	NULL
these	NULL
two	NULL
agents	NULL
were	NULL
enforced	NULL
not	NULL
only	NULL
at	NULL
the	NULL
level	NULL
of	NULL
cell	NULL
surface	NULL
protein	NULL
,	NULL
but	NULL
also	NULL
at	NULL
that	NULL
of	NULL
the	NULL
corresponding	NULL
transcripts	NULL
.	NULL

The	NULL
results	NULL
with	NULL
EGTA	NULL
as	NULL
a	NULL
representative	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

The	NULL
inhibitory	NULL
effects	NULL
of	NULL
TMB-8	NULL
and	NULL
EGTA	NULL
together	NULL
implicated	NULL
a	NULL
role	NULL
for	NULL
Ca	NULL
,	NULL
``	NULL
*	NULL
in	NULL
the	NULL
mediation	NULL
of	NULL
expression	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
REGULATION	NULL
OF	NULL
CD80	NULL
AND	NULL
CD86	NULL
EXPRESSION	NULL
IN	NULL
B	NULL
CELLS	NULL
B	NULL
a	NULL
anti-IgM	NULL
-o	NULL
+	NULL
0+	NULL
bp	NULL
anti-IgM	NULL
-	NULL
+	NULL
+	NULL
EGTA	NULL
2	NULL
20	NULL
,	NULL
anti-CD54	NULL
>	NULL
+	NULL
+	NULL
EGTA	NULL
-	NULL
-	NULL
+	NULL
CD	NULL
86	NULL
g.	NULL
co	NULL
so	NULL
___	NULL
i	NULL
.	NULL

FIGURE	NULL
2	NULL
.	NULL

EGTA	NULL
inhibits	NULL
induction	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
EGTA	NULL
addition	NULL
(	NULL
dashed	NULL
line	NULL
)	NULL
on	NULL
either	NULL
anti-IgM-dependent	NULL
CD86	NULL
induction	NULL
(	NULL
a	NULL
)	NULL
or	NULL
anti-IgM	NULL
plus	NULL
anti-CD54-mediated	NULL
CD80	NULL
up-regulation	NULL
(	NULL
b	NULL
)	NULL
are	NULL
shown	NULL
in	NULL
A	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
unstimulated	NULL
cells	NULL
are	NULL
represented	NULL
by	NULL
the	NULL
thin	NULL
line	NULL
,	NULL
and	NULL
staining	NULL
in	NULL
cells	NULL
stimulated	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
EGTA	NULL
are	NULL
depicted	NULL
by	NULL
the	NULL
thick	NULL
line	NULL
.	NULL

The	NULL
corresponding	NULL
effects	NULL
of	NULL
EGTA	NULL
on	NULL
the	NULL
respective	NULL
mRNA	NULL
levels	NULL
are	NULL
also	NULL
shown	NULL
in	NULL
B	NULL
.	NULL

Data	NULL
presented	NULL
here	NULL
are	NULL
a	NULL
representative	NULL
of	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

CD86	NULL
.	NULL

Consequently	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
BCR	NULL
and	NULL
CD54	NULL
ligation	NULL
on	NULL
Ca	NULL
,	NULL
*	NULL
``	NULL
mobilization	NULL
.	NULL

Consistent	NULL
with	NULL
prior	NULL
findings	NULL
(	NULL
for	NULL
a	NULL
review	NULL
,	NULL
see	NULL
Ref	NULL
.	NULL

29	NULL
)	NULL
,	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
anti-IgM	NULL
resulted	NULL
in	NULL
a	NULL
biphasic	NULL
recruitment	NULL
of	NULL
Ca**	NULL
ions	NULL
into	NULL
the	NULL
cy-toplasm	NULL
.	NULL

A	NULL
rapid	NULL
,	NULL
but	NULL
transient	NULL
,	NULL
increase	NULL
was	NULL
evident	NULL
immediately	NULL
upon	NULL
addition	NULL
of	NULL
anti-IgM	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Although	NULL
these	NULL
levels	NULL
declined	NULL
rapidly	NULL
,	NULL
they	NULL
nevertheless	NULL
stabilized	NULL
at	NULL
concentrations	NULL
significantly	NULL
above	NULL
the	NULL
baseline	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
first	NULL
,	NULL
rapid	NULL
,	NULL
phase	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
1,4,5-inositol	NULL
triphosphate-mediated	NULL
release	NULL
from	NULL
intracellular	NULL
stores	NULL
,	NULL
the	NULL
second	NULL
phase	NULL
of	NULL
low	NULL
but	NULL
sustained	NULL
elevation	NULL
has	NULL
been	NULL
ascribed	NULL
to	NULL
represent	NULL
capacitative	NULL
influx	NULL
mediated	NULL
by	NULL
the	NULL
calcium-release	NULL
activated	NULL
channels	NULL
(	NULL
CRAC	NULL
)	NULL
(	NULL
29-31	NULL
)	NULL
.	NULL

These	NULL
latter	NULL
channels	NULL
are	NULL
activated	NULL
upon	NULL
exhaustion	NULL
of	NULL
the	NULL
internal	NULL
pool	NULL
,	NULL
although	NULL
the	NULL
mechanism	NULL
by	NULL
which	NULL
this	NULL
occurs	NULL
is	NULL
not	NULL
known	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
keeping	NULL
with	NULL
the	NULL
above	NULL
interpretation	NULL
,	NULL
addition	NULL
of	NULL
TMB-8	NULL
markedly	NULL
inhibited	NULL
Ca	NULL
,	NULL
**	NULL
mobilization	NULL
by	NULL
B	NULL
cells	NULL
,	NULL
in	NULL
response	NULL
to	NULL
anti-IgM	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

As	NULL
opposed	NULL
to	NULL
this	NULL
,	NULL
EGTA	NULL
addition	NULL
selectively	NULL
suppressed	NULL
anti-IgM-mediated	NULL
capacitative	NULL
Ca**	NULL
in-flux	NULL
,	NULL
with	NULL
only	NULL
a	NULL
relatively	NULL
minor	NULL
effect	NULL
on	NULL
recruitment	NULL
from	NULL
intracellular	NULL
stores	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
)	NULL
.	NULL

Distinct	NULL
from	NULL
the	NULL
effects	NULL
of	NULL
anti-IgM	NULL
,	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
anti-CD54	NULL
had	NULL
no	NULL
detectable	NULL
influence	NULL
on	NULL
Ca	NULL
;	NULL
,	NULL
**	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
dual	NULL
stimulation	NULL
with	NULL
both	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
also	NULL
produced	NULL
no	NULL
additive	NULL
effect	NULL
,	NULL
yielding	NULL
a	NULL
profile	NULL
identical	NULL
with	NULL
that	NULL
obtained	NULL
upon	NULL
stimulation	NULL
with	NULL
anti-IgM	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
of	NULL
the	NULL
absence	NULL
of	NULL
any	NULL
effect	NULL
of	NULL
anti-€CD54	NULL
on	NULL
Ca	NULL
;	NULL
**	NULL
concentrations	NULL
in	NULL
B	NULL
cells	NULL
is	NULL
in	NULL
keeping	NULL
with	NULL
prior	NULL
find-ings	NULL
.	NULL

In	NULL
a	NULL
recent	NULL
study	NULL
,	NULL
van	NULL
Horssen	NULL
et	NULL
al	NULL
.	NULL

(	NULL
32	NULL
)	NULL
also	NULL
did	NULL
not	NULL
detect	NULL
Ca	NULL
,	NULL
**	NULL
mobilization	NULL
in	NULL
B	NULL
cells	NULL
upon	NULL
CD54	NULL
ligation	NULL
although	NULL
CD54	NULL
cross-linking	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
Ca	NULL
,	NULL
**	NULL
concentrations	NULL
in	NULL
rat	NULL
endothelial	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
whereas	NULL
Ca	NULL
,	NULL
**	NULL
was	NULL
identified	NULL
as	NULL
a	NULL
common	NULL
mediator	NULL
of	NULL
both	NULL
the	NULL
CD80	NULL
and	NULL
CD86	NULL
regulatory	NULL
path-ways	NULL
,	NULL
its	NULL
intracellular	NULL
mobilization	NULL
appeared	NULL
to	NULL
exclusively	NULL
derive	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
79	NULL
}	NULL
A	NULL
soo|	NULL
B	NULL
60	NULL
}	NULL
-wa	NULL
50	NULL
&	NULL
450	NULL
€	NULL
40/-	NULL
<	NULL
3	NULL
1	NULL
4	NULL
©300	NULL
o	NULL
30	NULL
n-	NULL
&	NULL
2	NULL
o	NULL
20	NULL
}	NULL
i159	NULL
108	NULL
%	NULL
0	NULL
1	NULL
1	NULL
_	NULL
L	NULL
1	NULL
0.25	NULL
0.50	NULL
0.75	NULL
10	NULL
1	NULL
0	NULL
200	NULL
400	NULL
600	NULL
Time	NULL
(	NULL
sec	NULL
)	NULL
Ionomycin	NULL
(	NULL
uM	NULL
)	NULL
D	NULL
u	NULL
3	NULL
@	NULL
2	NULL
6	NULL
&	NULL
ra	NULL
A	NULL
8	NULL
8	NULL
og	NULL
in	NULL
G	NULL
3	NULL
2	NULL
of	NULL
=	NULL
LJ	NULL
#	NULL
8	NULL
0	NULL
=	NULL
u	NULL
2	NULL
+	NULL
c	NULL
©	NULL
«	NULL
t	NULL
c	NULL
t	NULL
%	NULL
mot	NULL
tu	NULL
o	NULL
9	NULL
m	NULL
£	NULL
og	NULL
=	NULL
&	NULL
&	NULL
+	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Ca	NULL
,	NULL
;	NULL
**	NULL
mobilization	NULL
and	NULL
its	NULL
effect	NULL
on	NULL
CD80	NULL
and	NULL
CD86	NULL
levels	NULL
.	NULL

fluo-3-AM-loaded	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-IgM	NULL
either	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
profile	NULL
1	NULL
)	NULL
or	NULL
presence	NULL
of	NULL
either	NULL
EGTA	NULL
(	NULL
profile	NULL
2	NULL
)	NULL
or	NULL
TMB-8	NULL
(	NULL
profile	NULL
3	NULL
)	NULL
,	NULL
and	NULL
the	NULL
subsequent	NULL
recruitment	NULL
of	NULL
Ca	NULL
;	NULL
,	NULL
**	NULL
was	NULL
monitored	NULL
by	NULL
flow	NULL
cytometry	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
corresponding	NULL
effect	NULL
of	NULL
stimulating	NULL
cells	NULL
with	NULL
anti-CD54	NULL
is	NULL
also	NULL
shown	NULL
(	NULL
A	NULL
,	NULL
profile	NULL
4	NULL
)	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
graded	NULL
concentrations	NULL
of	NULL
ionomycin	NULL
,	NULL
and	NULL
the	NULL
peak	NULL
Ca**	NULL
obtained	NULL
at	NULL
each	NULL
concentration	NULL
was	NULL
averaged	NULL
over	NULL
a	NULL
10-min	NULL
period	NULL
.	NULL

The	NULL
graph	NULL
in	NULL
B	NULL
depicts	NULL
the	NULL
mean	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
four	NULL
separate	NULL
determinations	NULL
.	NULL

The	NULL
line	NULL
intersecting	NULL
the	NULL
graph	NULL
indicates	NULL
the	NULL
mean	NULL
Ca	NULL
;	NULL
**	NULL
concentration	NULL
obtained	NULL
during	NULL
the	NULL
EGTA-sensitive	NULL
phase	NULL
of	NULL
anti-IgM-stimulated	NULL
mobilization	NULL
(	NULL
4	NULL
)	NULL
,	NULL
where	NULL
the	NULL
dashed	NULL
lines	NULL
above	NULL
and	NULL
below	NULL
represent	NULL
the	NULL
SD	NULL
from	NULL
the	NULL
mean	NULL
(	NULL
=	NULL
6	NULL
)	NULL
.	NULL

C	NULL
and	NULL
D	NULL
,	NULL
Effects	NULL
of	NULL
indicated	NULL
stimuli	NULL
on	NULL
cell	NULL
surface	NULL
densities	NULL
of	NULL
CD86	NULL
(	NULL
C	NULL
)	NULL
and	NULL
CD80	NULL
(	NULL
D	NULL
)	NULL
.	NULL

Cells	NULL
,	NULL
Unstimulated	NULL
;	NULL
alg	NULL
,	NULL
anti-IgM	NULL
;	NULL
In	NULL
,	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
;	NULL
aCD	NULL
,	NULL
anti-CD54	NULL
.	NULL

Values	NULL
presented	NULL
are	NULL
in	NULL
terms	NULL
of	NULL
modal	NULL
fluorescence	NULL
intensity	NULL
(	NULL
MF	NULL
]	NULL
)	NULL
in	NULL
B220*	NULL
gated	NULL
cells	NULL
for	NULL
each	NULL
group	NULL
,	NULL
and	NULL
are	NULL
the	NULL
mean	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
four	NULL
separate	NULL
determinations	NULL
.	NULL

due	NULL
to	NULL
BCR	NULL
and	NULL
not	NULL
CD54	NULL
triggering	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
inhibitory	NULL
effect	NULL
of	NULL
EGTA	NULL
on	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
induction	NULL
also	NULL
localizes	NULL
the	NULL
capacitative	NULL
influx	NULL
phase	NULL
of	NULL
BCR-dependent	NULL
Ca	NULL
,	NULL
**	NULL
recruitment	NULL
as	NULL
the	NULL
key	NULL
regulatory	NULL
component	NULL
.	NULL

The	NULL
above	NULL
identification	NULL
of	NULL
a	NULL
role	NULL
for	NULL
BCR-mediated	NULL
capacitative	NULL
Ca**	NULL
influx	NULL
also	NULL
prompted	NULL
us	NULL
to	NULL
next	NULL
single	NULL
out	NULL
the	NULL
effects	NULL
due	NULL
to	NULL
this	NULL
second	NULL
messenger	NULL
.	NULL

Influx	NULL
of	NULL
Ca**	NULL
from	NULL
the	NULL
extracellular	NULL
milieu	NULL
can	NULL
readily	NULL
be	NULL
achieved	NULL
by	NULL
the	NULL
use	NULL
of	NULL
ionophores	NULL
such	NULL
as	NULL
ionomycin	NULL
(	NULL
34	NULL
,	NULL
35	NULL
)	NULL
.	NULL

However	NULL
,	NULL
to	NULL
maintain	NULL
parity	NULL
with	NULL
the	NULL
native	NULL
situation	NULL
,	NULL
we	NULL
first	NULL
performed	NULL
titration	NULL
experiments	NULL
to	NULL
determine	NULL
that	NULL
dose	NULL
of	NULL
ionomycin	NULL
that	NULL
would	NULL
induce	NULL
Ca**	NULL
influx	NULL
to	NULL
a	NULL
level	NULL
that	NULL
was	NULL
comparable	NULL
with	NULL
that	NULL
obtained	NULL
upon	NULL
anti-IgM	NULL
(	NULL
or	NULL
anti-IgM	NULL
plus	NULL
anti-€CD54	NULL
)	NULL
stimulation	NULL
.	NULL

For	NULL
this	NULL
,	NULL
B	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
ionomycin	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
Ca*	NULL
*	NULL
influx	NULL
was	NULL
monitored	NULL
.	NULL

The	NULL
cumulative	NULL
results	NULL
from	NULL
such	NULL
experiments	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
.	NULL

It	NULL
is	NULL
evident	NULL
from	NULL
this	NULL
figure	NULL
that	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
an	NULL
ionomycin	NULL
concentration	NULL
of	NULL
0.5	NULL
wM	NULL
mimics	NULL
the	NULL
capacitative	NULL
entry	NULL
phase	NULL
of	NULL
anti-IgM-stimulated	NULL
recruitment	NULL
of	NULL
calcium	NULL
ions	NULL
.	NULL

To	NULL
ascertain	NULL
the	NULL
specific	NULL
effects	NULL
of	NULL
this	NULL
Ca	NULL
,	NULL
``	NULL
*	NULL
concentration	NULL
,	NULL
we	NULL
next	NULL
used	NULL
0.5	NULL
M	NULL
ionomycin	NULL
as	NULL
the	NULL
stimulant	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3C	NULL
,	NULL
this	NULL
treatment	NULL
alone	NULL
was	NULL
sufficient	NULL
to	NULL
generate	NULL
an	NULL
increase	NULL
in	NULL
surface	NULL
CD86	NULL
expression	NULL
.	NULL

Importantly	NULL
,	NULL
the	NULL
magnitude	NULL
of	NULL
this	NULL
effect	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
obtained	NULL
upon	NULL
anti-IgM	NULL
stimulation	NULL
and	NULL
,	NULL
furthermore	NULL
,	NULL
was	NULL
EGTA	NULL
sensitive	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
its	NULL
effect	NULL
on	NULL
CD86	NULL
,	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
0.5	NULL
wM	NULL
ionomycin	NULL
alone	NULL
had	NULL
no	NULL
detectable	NULL
effect	NULL
on	NULL
surface	NULL
CD80	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

However	NULL
,	NULL
CD80	NULL
up-regulation	NULL
was	NULL
readily	NULL
achieved	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
0.5	NULL
M	NULL
ionomycin	NULL
and	NULL
anti-CD54	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
en-	NULL
117	NULL
hancement	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
anti-IgM	NULL
plus	NULL
anti-€CD54	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
this	NULL
effect	NULL
was	NULL
also	NULL
inhibited	NULL
upon	NULL
addition	NULL
of	NULL
EGTA	NULL
(	NULL
Fig	NULL
.	NULL

3D	NULL
)	NULL
.	NULL

The	NULL
collective	NULL
observations	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
,	NULL
C	NULL
and	NULL
D	NULL
,	NULL
that	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
could	NULL
duplicate	NULL
the	NULL
effects	NULL
of	NULL
anti-IgM	NULL
on	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
up-regulation	NULL
,	NULL
further	NULL
underscores	NULL
the	NULL
relevance	NULL
of	NULL
Ca	NULL
;	NULL
**	NULL
in	NULL
both	NULL
pathways	NULL
.	NULL

Importantly	NULL
,	NULL
these	NULL
findings	NULL
support	NULL
that	NULL
BCR-mediated	NULL
capacitative	NULL
Ca**	NULL
influx	NULL
is	NULL
at	NULL
least	NULL
sufficient	NULL
to	NULL
account	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
anti-IgM	NULL
on	NULL
induction	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
.	NULL

In	NULL
the	NULL
context	NULL
of	NULL
the	NULL
present	NULL
system	NULL
,	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

3	NULL
also	NULL
reveal	NULL
a	NULL
dual	NULL
role	NULL
for	NULL
Ca	NULL
,	NULL
**	NULL
.	NULL

Whereas	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
it	NULL
ensures	NULL
CD86	NULL
induction	NULL
,	NULL
it	NULL
also	NULL
appears	NULL
to	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
CD54-dependent	NULL
pathways	NULL
to	NULL
facilitate	NULL
CD80	NULL
up-regulation	NULL
.	NULL

cAMP	NULL
is	NULL
the	NULL
second	NULL
intracellular	NULL
messenger	NULL
that	NULL
governs	NULL
CD80	NULL
expression	NULL
Our	NULL
identification	NULL
of	NULL
the	NULL
regulatory	NULL
intermediate	NULL
provided	NULL
upon	NULL
BCR	NULL
stimulation	NULL
encouraged	NULL
us	NULL
to	NULL
explore	NULL
for	NULL
a	NULL
possible	NULL
counterpart	NULL
that	NULL
could	NULL
be	NULL
implicated	NULL
in	NULL
the	NULL
CD54-dependent	NULL
pathways	NULL
.	NULL

In	NULL
this	NULL
connection	NULL
,	NULL
earlier	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
addition	NULL
of	NULL
db-cAMP	NULL
could	NULL
result	NULL
in	NULL
CD80	NULL
up-regulation	NULL
in	NULL
B	NULL
lymphoma	NULL
cells	NULL
(	NULL
36	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
db-cAMP	NULL
concentration	NULL
required	NULL
was	NULL
high	NULL
(	NULL
600	NULL
wM	NULL
)	NULL
,	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
enhancement	NULL
(	NULL
~2-fold	NULL
)	NULL
was	NULL
modest	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
this	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
demonstrated	NULL
in	NULL
rat	NULL
astrocytes	NULL
that	NULL
engagement	NULL
of	NULL
CD54	NULL
by	NULL
specific	NULL
Ab	NULL
induced	NULL
intracellular	NULL
cAMP	NULL
accumulation	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
studies	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
cAMP	NULL
could	NULL
well	NULL
constitute	NULL
a	NULL
mediator	NULL
of	NULL
CD54-dependent	NULL
effects	NULL
on	NULL
CD80	NULL
levels	NULL
.	NULL

We	NULL
first	NULL
examined	NULL
the	NULL
effects	NULL
of	NULL
either	NULL
anti-IgM	NULL
,	NULL
ionomycin	NULL
(	NULL
0.5	NULL
M	NULL
)	NULL
,	NULL
anti-€CD54	NULL
,	NULL
or	NULL
relevant	NULL
combinations	NULL
of	NULL
these	NULL
,	NULL
on	NULL
cAMP	NULL
levels	NULL
within	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
from	NULL
such	NULL
experiments	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

44	NULL
.	NULL

As	NULL
expected	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
earlier	NULL
reports	NULL
(	NULL
38	NULL
)	NULL
,	NULL
in	NULL
“	NULL
23	NULL
A	NULL
``	NULL
*-	NULL
g	NULL
_	NULL
2160	NULL
|-	NULL
240|-a	NULL
&	NULL
120	NULL
|-	NULL
180	NULL
}	NULL
__	NULL
E	NULL
®	NULL
E	NULL
so-	NULL
120	NULL
|-	NULL
-f	NULL
*-82	NULL
a	NULL
40	NULL
so-2	NULL
0	NULL
1	NULL
I	NULL
1	NULL
bet	NULL
8	NULL
a	NULL
o	NULL
1.0	NULL
10.0	NULL
100.0	NULL
1000.0	NULL
2	NULL
re	NULL
db-cAMP	NULL
(	NULL
pM	NULL
)	NULL
=	NULL
a	NULL
_	NULL
o	NULL
t	NULL
a	NULL
-	NULL
6	NULL
$	NULL
o	NULL
t	NULL
o	NULL
er	NULL
*s	NULL
&	NULL
C	NULL
,	NULL
_	NULL
80	NULL
}	NULL
-m	NULL
Z	NULL
60	NULL
}	NULL
-S	NULL
s	NULL
40	NULL
)	NULL
2	NULL
&	NULL
o	NULL
(	NULL
100	NULL
)	NULL
In+dbe	NULL
(	NULL
100	NULL
)	NULL
ho	NULL
52	NULL
F	NULL
|F	NULL
F	NULL
F	NULL
abe	NULL
(	NULL
100	NULL
)	NULL
|	NULL
J	NULL
swag	NULL
In+dbc	NULL
(	NULL
20	NULL
)	NULL
j	NULL
alg	NULL
{	NULL
aCD	NULL
In+aCD	NULL
alg+d	NULL
be	NULL
Cells	NULL
alg	NULL
n	NULL
C	NULL
FIGURE	NULL
4	NULL
.	NULL

-	NULL
Regulation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
and	NULL
its	NULL
consequences	NULL
on	NULL
costimulatory	NULL
molecule	NULL
expression	NULL
.	NULL

The	NULL
data	NULL
in	NULL
A	NULL
depict	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
various	NULL
stimuli	NULL
used	NULL
on	NULL
intracellular	NULL
cAMP	NULL
concentrations	NULL
in	NULL
purified	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
a	NULL
separate	NULL
experiment	NULL
,	NULL
cells	NULL
were	NULL
also	NULL
stimulated	NULL
with	NULL
indicated	NULL
concentrations	NULL
of	NULL
db-cAMP	NULL
,	NULL
and	NULL
the	NULL
resultant	NULL
intracellular	NULL
accumulation	NULL
was	NULL
measured	NULL
(	NULL
B	NULL
)	NULL
.	NULL

The	NULL
lines	NULL
intercepting	NULL
the	NULL
graph	NULL
,	NULL
numbered	NULL
1	NULL
and	NULL
2	NULL
,	NULL
represent	NULL
intracellular	NULL
cAMP	NULL
concentrations	NULL
(	NULL
dashed	NULL
lines	NULL
representing	NULL
SD	NULL
)	NULL
obtained	NULL
in	NULL
response	NULL
to	NULL
stimulation	NULL
of	NULL
cells	NULL
either	NULL
with	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
,	NULL
or	NULL
with	NULL
anti-CD54	NULL
alone	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
data	NULL
in	NULL
C	NULL
depict	NULL
cell	NULL
surface	NULL
CD80	NULL
staining	NULL
in	NULL
B220+*	NULL
gated	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
the	NULL
indicated	NULL
stimuli	NULL
.	NULL

Cells	NULL
,	NULL
Unstimulated	NULL
;	NULL
alg	NULL
,	NULL
anti-IgM	NULL
;	NULL
In	NULL
,	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
;	NULL
dbe	NULL
(	NULL
20	NULL
)	NULL
,	NULL
20	NULL
uM	NULL
db-cAMP	NULL
;	NULL
dbe	NULL
(	NULL
100	NULL
)	NULL
,	NULL
100	NULL
uM	NULL
db-cAMP	NULL
;	NULL
aCD	NULL
,	NULL
anti-CD54	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
at	NULL
least	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
118	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
anti-IgM	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
cAMP	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

This	NULL
was	NULL
also	NULL
true	NULL
when	NULL
ionomycin	NULL
was	NULL
used	NULL
instead	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
this	NULL
,	NULL
addition	NULL
of	NULL
anti-CD54	NULL
was	NULL
found	NULL
to	NULL
produce	NULL
a	NULL
near	NULL
5-fold	NULL
increase	NULL
,	NULL
implying	NULL
that	NULL
CD54	NULL
stimulation	NULL
also	NULL
leads	NULL
to	NULL
accumulation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
however	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-€CD54	NULL
as	NULL
stimulants	NULL
proved	NULL
markedly	NULL
more	NULL
effective	NULL
,	NULL
yielding	NULL
a	NULL
near	NULL
15-fold	NULL
elevation	NULL
in	NULL
cAMP	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
although	NULL
BCR	NULL
triggering	NULL
alone	NULL
was	NULL
ineffective	NULL
,	NULL
it	NULL
nevertheless	NULL
appeared	NULL
to	NULL
synergize	NULL
with	NULL
CD54	NULL
stimulation	NULL
to	NULL
generate	NULL
an	NULL
amplified	NULL
cAMP	NULL
response	NULL
.	NULL

Equally	NULL
significant	NULL
here	NULL
was	NULL
our	NULL
finding	NULL
that	NULL
the	NULL
synergistic	NULL
effect	NULL
of	NULL
anti-IgM	NULL
on	NULL
CD54-dependent	NULL
cAMP	NULL
accumulation	NULL
could	NULL
readily	NULL
be	NULL
duplicated	NULL
upon	NULL
substituting	NULL
it	NULL
with	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

A	NULL
comparable	NULL
extent	NULL
of	NULL
enhancement	NULL
in	NULL
intracellular	NULL
cAMP	NULL
concentrations	NULL
was	NULL
obtained	NULL
regardless	NULL
of	NULL
whether	NULL
anti-IgM	NULL
or	NULL
ionomycin	NULL
was	NULL
used	NULL
in	NULL
conjunction	NULL
with	NULL
anti-CD54	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
these	NULL
latter	NULL
results	NULL
,	NULL
we	NULL
infer	NULL
that	NULL
anti-IgM-mobilized	NULL
Ca	NULL
,	NULL
**	NULL
constitutes	NULL
at	NULL
least	NULL
the	NULL
principle	NULL
mediator	NULL
of	NULL
the	NULL
synergistic	NULL
effects	NULL
of	NULL
anti-IgM	NULL
on	NULL
CD54-dependent	NULL
enhancement	NULL
of	NULL
intracellular	NULL
cAMP	NULL
.	NULL

Consistent	NULL
with	NULL
such	NULL
an	NULL
interpretation	NULL
,	NULL
the	NULL
amplifying	NULL
effects	NULL
of	NULL
both	NULL
anti-IgM	NULL
and	NULL
ionomycin	NULL
on	NULL
CD54-dependent	NULL
cAMP	NULL
accumulation	NULL
could	NULL
be	NULL
abolished	NULL
by	NULL
the	NULL
simultaneous	NULL
inclusion	NULL
of	NULL
EGTA	NULL
in	NULL
the	NULL
cultures	NULL
.	NULL

In	NULL
both	NULL
instances	NULL
,	NULL
the	NULL
cAMP	NULL
responses	NULL
were	NULL
similar	NULL
to	NULL
that	NULL
obtained	NULL
upon	NULL
stimulation	NULL
with	NULL
anti-CD54	NULL
alone	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
directly	NULL
evaluate	NULL
the	NULL
consequences	NULL
of	NULL
enhanced	NULL
cAMP	NULL
concentrations	NULL
on	NULL
CD80	NULL
levels	NULL
,	NULL
we	NULL
next	NULL
used	NULL
its	NULL
analog	NULL
db-cAMP	NULL
.	NULL

However	NULL
,	NULL
to	NULL
maintain	NULL
equivalence	NULL
with	NULL
the	NULL
native	NULL
situation	NULL
,	NULL
we	NULL
sought	NULL
to	NULL
use	NULL
db-cAMP	NULL
at	NULL
a	NULL
concentration	NULL
that	NULL
would	NULL
mimic	NULL
the	NULL
effects	NULL
of	NULL
either	NULL
anti-CD54	NULL
alone	NULL
or	NULL
that	NULL
of	NULL
anti-€CD54	NULL
plus	NULL
anti-IgM	NULL
.	NULL

For	NULL
this	NULL
,	NULL
titration	NULL
experiments	NULL
were	NULL
first	NULL
performed	NULL
wherein	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
db-cAMP	NULL
,	NULL
and	NULL
the	NULL
consequent	NULL
intracellular	NULL
levels	NULL
then	NULL
measured	NULL
.	NULL

The	NULL
results	NULL
from	NULL
such	NULL
experiments	NULL
are	NULL
summarized	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
.	NULL

From	NULL
these	NULL
results	NULL
it	NULL
was	NULL
estimated	NULL
that	NULL
a	NULL
20	NULL
wM	NULL
concentration	NULL
of	NULL
db-cAMP	NULL
would	NULL
mimic	NULL
the	NULL
effects	NULL
of	NULL
anti-CD54	NULL
alone	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
cAMP	NULL
response	NULL
upon	NULL
dual	NULL
stimulation	NULL
with	NULL
anti-CD54	NULL
and	NULL
anti-IgM	NULL
(	NULL
or	NULL
ionomycin	NULL
)	NULL
could	NULL
be	NULL
duplicated	NULL
by	NULL
using	NULL
db-cAMP	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
100	NULL
uM	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
compare	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Our	NULL
next	NULL
objective	NULL
was	NULL
to	NULL
assess	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
above	NULL
titrated	NULL
doses	NULL
of	NULL
db-cAMP	NULL
,	NULL
either	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
other	NULL
stimuli	NULL
,	NULL
on	NULL
CD80	NULL
expression	NULL
.	NULL

The	NULL
results	NULL
from	NULL
such	NULL
experiments	NULL
are	NULL
depicted	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
,	NULL
and	NULL
several	NULL
interesting	NULL
aspects	NULL
may	NULL
be	NULL
noted	NULL
here	NULL
.	NULL

Although	NULL
the	NULL
combined	NULL
stimulation	NULL
with	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
leads	NULL
to	NULL
amplified	NULL
cAMP	NULL
accumulation	NULL
,	NULL
this	NULL
alone	NULL
appeared	NULL
to	NULL
be	NULL
insufficient	NULL
to	NULL
explain	NULL
the	NULL
effect	NULL
on	NULL
CD80	NULL
levels	NULL
.	NULL

This	NULL
became	NULL
evident	NULL
from	NULL
the	NULL
fact	NULL
that	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
100	NULL
wM	NULL
db-cAMP	NULL
alone	NULL
had	NULL
no	NULL
significant	NULL
effect	NULL
on	NULL
surface	NULL
CD80	NULL
densities	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
though	NULL
,	NULL
a	NULL
combination	NULL
of	NULL
100	NULL
uM	NULL
db-cAMP	NULL
and	NULL
anti-IgM	NULL
proved	NULL
extremely	NULL
effective	NULL
,	NULL
producing	NULL
an	NULL
enhancement	NULL
in	NULL
CD80	NULL
levels	NULL
that	NULL
was	NULL
comparable	NULL
to	NULL
that	NULL
obtained	NULL
upon	NULL
stimulation	NULL
with	NULL
anti-IgM	NULL
plus	NULL
anti-€CD54	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
cAMP	NULL
,	NULL
up-regulation	NULL
of	NULL
CD80	NULL
also	NULL
required	NULL
an	NULL
added	NULL
contribution	NULL
from	NULL
BCR-dependent	NULL
pathways	NULL
.	NULL

Another	NULL
important	NULL
finding	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
was	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
stimulus	NULL
of	NULL
anti-IgM	NULL
could	NULL
again	NULL
be	NULL
substituted	NULL
with	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
,	NULL
without	NULL
any	NULL
loss	NULL
in	NULL
potency	NULL
.	NULL

Thus	NULL
the	NULL
combination	NULL
of	NULL
100	NULL
wM	NULL
db-cAMP	NULL
and	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
the	NULL
parent	NULL
stimulus	NULL
of	NULL
anti-€CD54	NULL
plus	NULL
anti-IgM	NULL
at	NULL
up-regulating	NULL
CD80	NULL
on	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
data	NULL
suggest	NULL
that	NULL
the	NULL
BCR-mobilized	NULL
Ca	NULL
,	NULL
**	NULL
by	NULL
way	NULL
of	NULL
capacitative	NULL
influx	NULL
again	NULL
constitutes	NULL
the	NULL
key	NULL
entity	NULL
responsible	NULL
for	NULL
cooperating	NULL
with	NULL
cAMP-dependent	NULL
path-ways	NULL
,	NULL
to	NULL
increase	NULL
CD80	NULL
expression	NULL
.	NULL

REGULATION	NULL
OF	NULL
CD80	NULL
AND	NULL
CD86	NULL
EXPRESSION	NULL
IN	NULL
B	NULL
CELLS	NULL
The	NULL
cumulative	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
also	NULL
reveal	NULL
the	NULL
existence	NULL
of	NULL
an	NULL
iterative	NULL
interplay	NULL
between	NULL
BCR-	NULL
and	NULL
CD54-stimulated	NULL
biochemical	NULL
pathways	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
implicating	NULL
Ca	NULL
,	NULL
**	NULL
and	NULL
cAMP	NULL
as	NULL
the	NULL
two	NULL
principal	NULL
second	NULL
messengers	NULL
involved	NULL
,	NULL
these	NULL
data	NULL
also	NULL
highlight	NULL
a	NULL
sequential	NULL
partitioning	NULL
of	NULL
function	NULL
for	NULL
the	NULL
BCR-recruited	NULL
Ca	NULL
,	NULL
``	NULL
*	NULL
.	NULL

At	NULL
one	NULL
level	NULL
this	NULL
Ca	NULL
,	NULL
**	NULL
was	NULL
found	NULL
to	NULL
synergize	NULL
with	NULL
CD54	NULL
stimulation	NULL
to	NULL
produce	NULL
an	NULL
amplified	NULL
intracellular	NULL
cAMP	NULL
response	NULL
(	NULL
Fig	NULL
.	NULL

44	NULL
)	NULL
.	NULL

However	NULL
,	NULL
subsequent	NULL
to	NULL
this	NULL
,	NULL
Ca	NULL
,	NULL
;	NULL
**	NULL
again	NULL
appeared	NULL
to	NULL
integrate	NULL
with	NULL
pathways	NULL
dependent	NULL
upon	NULL
cAMP	NULL
,	NULL
to	NULL
yield	NULL
an	NULL
increase	NULL
in	NULL
CD80	NULL
expression	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

That	NULL
the	NULL
synergistic	NULL
cAMP	NULL
response	NULL
was	NULL
a	NULL
necessary	NULL
prerequisite	NULL
to	NULL
the	NULL
latter	NULL
effect	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
data	NULL
in	NULL
Fig	NULL
.	NULL

4C	NULL
.	NULL

As	NULL
shown	NULL
here	NULL
,	NULL
reducing	NULL
the	NULL
db-cAMP	NULL
concentration	NULL
from	NULL
100	NULL
to	NULL
20	NULL
wM	NULL
,	NULL
a	NULL
dose	NULL
that	NULL
mimics	NULL
the	NULL
effects	NULL
of	NULL
anti-CD54	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
)	NULL
,	NULL
during	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
either	NULL
db-cAMP	NULL
and	NULL
anti-IgM	NULL
or	NULL
with	NULL
db-cAMP	NULL
and	NULL
ionomycin	NULL
,	NULL
markedly	NULL
reduced	NULL
the	NULL
efficiency	NULL
of	NULL
CD80	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

4C	NULL
)	NULL
.	NULL

BCR-	NULL
and	NULL
CD5S4-dependent	NULL
pathways	NULL
also	NULL
converge	NULL
to	NULL
synergize	NULL
CREB	NULL
phosphorylation	NULL
at	NULL
Ser'*	NULL
The	NULL
concerted	NULL
action	NULL
of	NULL
Ca	NULL
,	NULL
``	NULL
*	NULL
and	NULL
cAMP	NULL
signaling	NULL
pathways	NULL
on	NULL
CD80	NULL
expression	NULL
was	NULL
particularly	NULL
intriguing	NULL
,	NULL
and	NULL
deserved	NULL
further	NULL
scrutiny	NULL
.	NULL

However	NULL
,	NULL
any	NULL
information	NULL
on	NULL
the	NULL
transcription	NULL
factors	NULL
that	NULL
directly	NULL
regulate	NULL
activation	NULL
of	NULL
the	NULL
CD80	NULL
gene	NULL
is	NULL
currently	NULL
lack-ing	NULL
.	NULL

Furthermore	NULL
,	NULL
considering	NULL
the	NULL
delayed	NULL
kinetics	NULL
of	NULL
induction	NULL
of	NULL
CD80	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1Ac	NULL
,	NULL
it	NULL
is	NULL
entirely	NULL
possible	NULL
that	NULL
these	NULL
two	NULL
pathways	NULL
act	NULL
on	NULL
early	NULL
transcriptional	NULL
events	NULL
,	NULL
which	NULL
then	NULL
regulate	NULL
CD80	NULL
concentrations	NULL
either	NULL
at	NULL
the	NULL
level	NULL
of	NULL
transcript	NULL
stabilization	NULL
or	NULL
de	NULL
novo	NULL
synthesis	NULL
.	NULL

Therefore	NULL
,	NULL
as	NULL
an	NULL
alternative	NULL
,	NULL
we	NULL
explored	NULL
the	NULL
effects	NULL
on	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
.	NULL

Activation	NULL
of	NULL
CREB	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
minimally	NULL
require	NULL
its	NULL
phosphorylation	NULL
on	NULL
a	NULL
Ser	NULL
residue	NULL
at	NULL
position	NULL
133	NULL
(	NULL
38-40	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
not	NULL
known	NULL
whether	NULL
CREB	NULL
in	NULL
fact	NULL
influences	NULL
CD80	NULL
expression	NULL
,	NULL
several	NULL
reasons	NULL
prompted	NULL
us	NULL
to	NULL
choose	NULL
this	NULL
particular	NULL
protein	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
identified	NULL
an	NULL
octamer	NULL
sequence	NULL
(	NULL
sequence	NULL
:	NULL
TGATGTCA	NULL
)	NULL
located	NULL
713	NULL
bp	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
in	NULL
the	NULL
murine	NULL
CD80	NULL
gene	NULL
,	NULL
that	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
CREB	NULL
in	NULL
gel-shift	NULL
assays	NULL
(	NULL
K.	NULL
Natarajan	NULL
,	NULL
and	NULL
K.V.S	NULL
.	NULL

Rao	NULL
,	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Importantly	NULL
we	NULL
found	NULL
that	NULL
the	NULL
induction	NULL
of	NULL
CD80	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
could	NULL
be	NULL
completely	NULL
inhibited	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
H89	NULL
,	NULL
an	NULL
inhibitor	NULL
of	NULL
the	NULL
cAMP-dependent	NULL
kinase	NULL
,	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
(	NULL
41	NULL
,	NULL
42	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
the	NULL
inhibition	NULL
was	NULL
specific	NULL
for	NULL
CD80	NULL
,	NULL
and	NULL
was	NULL
exercised	NULL
at	NULL
the	NULL
level	NULL
of	NULL
both	NULL
cell	NULL
surface	NULL
protein	NULL
and	NULL
the	NULL
corresponding	NULL
mRNA	NULL
.	NULL

Because	NULL
CREB	NULL
is	NULL
known	NULL
to	NULL
represent	NULL
the	NULL
principal	NULL
substrate	NULL
for	NULL
PKA	NULL
activity	NULL
(	NULL
39-41	NULL
)	NULL
,	NULL
these	NULL
findings	NULL
may	NULL
im-plicate	NULL
,	NULL
albeit	NULL
indirectly	NULL
,	NULL
a	NULL
possible	NULL
role	NULL
for	NULL
this	NULL
transcription	NULL
factor	NULL
during	NULL
CD80	NULL
regulation	NULL
.	NULL

Finally	NULL
,	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
Ser'*	NULL
>	NULL
of	NULL
CREB	NULL
serves	NULL
as	NULL
a	NULL
target	NULL
for	NULL
both	NULL
BCR-	NULL
and	NULL
cAMP-dependent	NULL
pathways	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
38	NULL
,	NULL
43	NULL
)	NULL
.	NULL

As	NULL
a	NULL
result	NULL
it	NULL
was	NULL
anticipated	NULL
that	NULL
,	NULL
at	NULL
the	NULL
minimum	NULL
,	NULL
CREB	NULL
could	NULL
serve	NULL
as	NULL
a	NULL
useful	NULL
substrate	NULL
to	NULL
demonstrate	NULL
the	NULL
existence	NULL
of	NULL
cooperativity	NULL
between	NULL
BCR-	NULL
and	NULL
CD54-stimulated	NULL
pathways	NULL
.	NULL

It	NULL
has	NULL
previously	NULL
been	NULL
demonstrated	NULL
that	NULL
stimulation	NULL
of	NULL
murine	NULL
B	NULL
lymphoma	NULL
cells	NULL
with	NULL
anti-IgM	NULL
results	NULL
in	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
(	NULL
38	NULL
)	NULL
.	NULL

The	NULL
predominant	NULL
kinase	NULL
implicated	NULL
in	NULL
this	NULL
appeared	NULL
to	NULL
be	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
rather	NULL
than	NULL
PKA	NULL
,	NULL
as	NULL
identified	NULL
by	NULL
the	NULL
effects	NULL
of	NULL
specific	NULL
inhibitors	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
findings	NULL
,	NULL
we	NULL
observed	NULL
that	NULL
stimulation	NULL
of	NULL
splenic	NULL
B	NULL
cells	NULL
with	NULL
anti-IgM	NULL
also	NULL
induced	NULL
Ser'*	NULL
``	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
,	NULL
although	NULL
the	NULL
magnitude	NULL
of	NULL
this	NULL
response	NULL
was	NULL
significantly	NULL
lower	NULL
(	NULL
~3-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
phosphorylation	NULL
was	NULL
inhibited	NULL
to	NULL
approximately	NULL
equal	NULL
extents	NULL
(	NULL
between	NULL
30	NULL
and	NULL
40	NULL
%	NULL
)	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
either	NULL
the	NULL
calmodulin-dependent	NULL
kinase	NULL
II/IV	NULL
inhibitor	NULL
KN-62	NULL
(	NULL
44	NULL
,	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Q	NULL
anti-IgM	NULL
-	NULL
-	NULL
0	NULL
+	NULL
+	NULL
D	NULL
anti-IgM	NULL
H89	NULL
Dol	NULL
&	NULL
anti-CD54	NULL
|	NULL
-	NULL
+	NULL
+	NULL
H89	NULL
-	NULL
-	NULL
+	NULL
thi	NULL
wig	NULL
Sue	NULL
CD	NULL
80	NULL
Talk	NULL
SB	NULL
)	NULL
ue	NULL
FIGURE	NULL
5	NULL
.	NULL

The	NULL
PKA	NULL
inhibitor	NULL
,	NULL
H89	NULL
,	NULL
inhibits	NULL
CD80	NULL
but	NULL
not	NULL
CD86	NULL
up-regulation	NULL
.	NULL

A	NULL
,	NULL
Effects	NULL
of	NULL
H89	NULL
addition	NULL
on	NULL
anti-IgM-mediated	NULL
induction	NULL
of	NULL
CD86	NULL
(	NULL
a	NULL
)	NULL
and	NULL
anti-IgM	NULL
plus	NULL
anti-CD54-dependent	NULL
up-regulation	NULL
of	NULL
CD80	NULL
(	NULL
b	NULL
)	NULL
,	NULL
respectively	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
the	NULL
thin	NULL
line	NULL
represents	NULL
unstimulated	NULL
cells	NULL
,	NULL
whereas	NULL
the	NULL
thick	NULL
line	NULL
represents	NULL
either	NULL
CD86	NULL
(	NULL
a	NULL
)	NULL
or	NULL
CD80	NULL
(	NULL
b	NULL
)	NULL
in	NULL
appropriately	NULL
stimulated	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
the	NULL
dashed	NULL
line	NULL
depicts	NULL
the	NULL
corresponding	NULL
levels	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
H89	NULL
(	NULL
100	NULL
nM	NULL
,	NULL
2	NULL
%	NULL
IC	NULL
;	NULL
,	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Northern	NULL
blot	NULL
analyses	NULL
for	NULL
either	NULL
CD86	NULL
(	NULL
a	NULL
)	NULL
or	NULL
CD80	NULL
(	NULL
b	NULL
)	NULL
mRNAs	NULL
obtained	NULL
in	NULL
the	NULL
individual	NULL
groups	NULL
.	NULL

Parallel	NULL
analysis	NULL
for	NULL
the	NULL
B-actin	NULL
message	NULL
confirmed	NULL
comparable	NULL
loading	NULL
in	NULL
all	NULL
cases	NULL
,	NULL
although	NULL
these	NULL
results	NULL
are	NULL
not	NULL
shown	NULL
here	NULL
.	NULL

Data	NULL
presented	NULL
are	NULL
from	NULL
one	NULL
of	NULL
three	NULL
separate	NULL
experiments	NULL
.	NULL

CD	NULL
86	NULL
45	NULL
)	NULL
or	NULL
the	NULL
PKC	NULL
inhibitor	NULL
calphostin	NULL
C	NULL
(	NULL
46	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

No	NULL
significant	NULL
effect	NULL
of	NULL
the	NULL
PKA	NULL
inhibitor	NULL
,	NULL
H89	NULL
,	NULL
could	NULL
be	NULL
detected	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
anti-IgM-stimulated	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
Ser'*	NULL
>	NULL
in	NULL
B	NULL
cells	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
,	NULL
at	NULL
least	NULL
largely	NULL
,	NULL
by	NULL
the	NULL
combined	NULL
activities	NULL
of	NULL
calmodulin-dependent	NULL
kinase	NULL
II/IV	NULL
and	NULL
PKC	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
,	NULL
addition	NULL
of	NULL
a	NULL
mixture	NULL
of	NULL
KN-62	NULL
and	NULL
calphostin	NULL
C	NULL
completely	NULL
abrogated	NULL
anti-IgM-dependent	NULL
CREB	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

64	NULL
)	NULL
.	NULL

In	NULL
similarity	NULL
to	NULL
anti-IgM	NULL
,	NULL
stimulation	NULL
with	NULL
anti-CD54	NULL
also	NULL
led	NULL
to	NULL
a	NULL
near	NULL
5-fold	NULL
enhancement	NULL
in	NULL
Ser'*	NULL
>	NULL
-phosphorylated	NULL
CREB	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
this	NULL
case	NULL
the	NULL
effect	NULL
appeared	NULL
to	NULL
be	NULL
principally	NULL
mediated	NULL
by	NULL
PKA	NULL
because	NULL
addition	NULL
of	NULL
H89	NULL
yielded	NULL
near	NULL
complete	NULL
inhibition	NULL
,	NULL
whereas	NULL
neither	NULL
KN-62	NULL
nor	NULL
calphostin	NULL
C	NULL
had	NULL
any	NULL
detectable	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
)	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
although	NULL
both	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
individually	NULL
drive	NULL
CREB	NULL
phosphorylation	NULL
at	NULL
they	NULL
apparently	NULL
recruit	NULL
distinct	NULL
protein	NULL
kinases	NULL
to	NULL
achieve	NULL
this	NULL
.	NULL

In	NULL
comparison	NULL
with	NULL
the	NULL
relatively	NULL
weak	NULL
individual	NULL
potencies	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
,	NULL
simultaneous	NULL
activation	NULL
with	NULL
both	NULL
of	NULL
these	NULL
stimuli	NULL
produced	NULL
a	NULL
markedly	NULL
pronounced	NULL
effect	NULL
,	NULL
yielding	NULL
a	NULL
near	NULL
20-fold	NULL
enhancement	NULL
in	NULL
levels	NULL
of	NULL
the	NULL
Ser'*	NULL
>	NULL
-phosphorylated	NULL
form	NULL
of	NULL
CREB	NULL
(	NULL
Fig	NULL
.	NULL

74	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
partial	NULL
inhibition	NULL
of	NULL
this	NULL
effect	NULL
was	NULL
obtained	NULL
with	NULL
KN-62	NULL
(	NULL
25	NULL
%	NULL
)	NULL
,	NULL
calphostin	NULL
C	NULL
(	NULL
20	NULL
%	NULL
)	NULL
,	NULL
or	NULL
H89	NULL
,	NULL
although	NULL
the	NULL
effects	NULL
of	NULL
H89	NULL
were	NULL
the	NULL
most	NULL
pronounced	NULL
,	NULL
where	NULL
inhibition	NULL
was	NULL
>	NULL
75	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Simultaneous	NULL
addition	NULL
of	NULL
all	NULL
three	NULL
of	NULL
these	NULL
inhibitors	NULL
resulted	NULL
in	NULL
a	NULL
complete	NULL
inhibition	NULL
of	NULL
phosphorylation	NULL
(	NULL
Fig	NULL
.	NULL

74	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
synergistic	NULL
effects	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
on	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
CREB	NULL
appear	NULL
to	NULL
reflect	NULL
the	NULL
cumulative	NULL
effects	NULL
of	NULL
the	NULL
protein	NULL
kinases	NULL
individually	NULL
recruited	NULL
by	NULL
these	NULL
stimuli	NULL
.	NULL

However	NULL
,	NULL
it	NULL
was	NULL
notable	NULL
that	NULL
a	NULL
substantial	NULL
proportion	NULL
of	NULL
the	NULL
enhanced	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
at	NULL
Ser'*	NULL
>	NULL
was	NULL
dependent	NULL
upon	NULL
PKA	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

119	NULL
Ser	NULL
‘	NULL
33—phosphorylcted	NULL
CREB	NULL
(	NULL
fold	NULL
induction	NULL
)	NULL
Inhibitor	NULL
0.5	NULL
1.0	NULL
20	NULL
30	NULL
4.0	NULL
A	NULL
None	NULL
KN-62	NULL
Cal-C	NULL
H	NULL
89	NULL
KN-62+Ca	NULL
0.7515	NULL
3.0	NULL
4.5	NULL
6.0	NULL
None	NULL
KN-62	NULL
Cal-C	NULL
H	NULL
89	NULL
FIGURE	NULL
6	NULL
.	NULL

Effects	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
on	NULL
CREB	NULL
phosphorylation	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Purified	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-IgM	NULL
(	NULL
4	NULL
)	NULL
or	NULL
with	NULL
anti-CD54	NULL
(	NULL
B	NULL
)	NULL
either	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
indicated	NULL
protein	NULL
kinase	NULL
inhibitors	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

Subsequently	NULL
prepared	NULL
nuclear	NULL
extracts	NULL
were	NULL
then	NULL
resolved	NULL
by	NULL
gel	NULL
electrophoresis	NULL
,	NULL
and	NULL
the	NULL
extent	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
was	NULL
determined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
using	NULL
Abs	NULL
specific	NULL
for	NULL
Ser'*	NULL
>	NULL
-phosphorylated	NULL
CREB	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Following	NULL
this	NULL
,	NULL
bound	NULL
Ab	NULL
was	NULL
eluted	NULL
,	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
reprobed	NULL
with	NULL
Abs	NULL
against	NULL
the	NULL
CREB	NULL
protein	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
enhancement	NULL
in	NULL
Ser'**-phosphorylation	NULL
was	NULL
determined	NULL
by	NULL
densitometric	NULL
scanning	NULL
of	NULL
the	NULL
resulting	NULL
autoradiograms	NULL
,	NULL
and	NULL
is	NULL
presented	NULL
as	NULL
fold	NULL
induction	NULL
over	NULL
that	NULL
in	NULL
unstimulated	NULL
cells	NULL
after	NULL
normalizing	NULL
for	NULL
CREB	NULL
protein	NULL
levels	NULL
in	NULL
each	NULL
lane	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
three	NULL
independent	NULL
determinations	NULL
.	NULL

Cal-C	NULL
,	NULL
Calphostin	NULL
C.	NULL
The	NULL
synergistic	NULL
influence	NULL
of	NULL
anti-IgM	NULL
and	NULL
anti-CD54	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
could	NULL
also	NULL
be	NULL
duplicated	NULL
by	NULL
substituting	NULL
these	NULL
stimuli	NULL
with	NULL
0.5	NULL
wM	NULL
ionomycin	NULL
and	NULL
100	NULL
uM	NULL
db-cAMP	NULL
,	NULL
respectively	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
the	NULL
various	NULL
inhibitors	NULL
tested	NULL
also	NULL
yielded	NULL
results	NULL
comparable	NULL
with	NULL
that	NULL
obtained	NULL
for	NULL
anti-IgM	NULL
plus	NULL
anti-€CD54	NULL
stimulation	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
,	NULL
compare	NULL
A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
KN-62	NULL
and	NULL
calphostin	NULL
C	NULL
inhibited	NULL
CREB	NULL
phosphorylation	NULL
at	NULL
Ser'*	NULL
>	NULL
by	NULL
25	NULL
and	NULL
20	NULL
%	NULL
,	NULL
respectively	NULL
,	NULL
inhibition	NULL
by	NULL
H89	NULL
was	NULL
by	NULL
as	NULL
much	NULL
as	NULL
80	NULL
%	NULL
.	NULL

At	NULL
one	NULL
level	NULL
,	NULL
these	NULL
data	NULL
confirm	NULL
that	NULL
,	NULL
in	NULL
similarity	NULL
with	NULL
CD80	NULL
induction	NULL
,	NULL
Ca	NULL
,	NULL
**	NULL
and	NULL
cAMP	NULL
again	NULL
constitute	NULL
the	NULL
principal	NULL
intracellular	NULL
mediators	NULL
that	NULL
direct	NULL
the	NULL
downstream	NULL
effects	NULL
of	NULL
BCR	NULL
and	NULL
CD54	NULL
ligation	NULL
on	NULL
CREB	NULL
phosphorylation	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
highlighted	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
kinase	NULL
intermediates	NULL
recruited	NULL
by	NULL
ionomycin	NULL
plus	NULL
db-cAMP	NULL
in	NULL
this	NULL
process	NULL
are	NULL
the	NULL
same	NULL
as	NULL
those	NULL
mobilized	NULL
by	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
.	NULL

In	NULL
either	NULL
case	NULL
a	NULL
biased	NULL
requirement	NULL
for	NULL
PKA	NULL
activity	NULL
could	NULL
also	NULL
be	NULL
noted	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
results	NULL
in	NULL
Fig	NULL
.	NULL

7	NULL
clearly	NULL
identify	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
productive	NULL
cross-talk	NULL
between	NULL
BCR-stimulated	NULL
Ca	NULL
,	NULL
**	NULL
``	NULL
and	NULL
intracellular	NULL
cAMP	NULL
signaling	NULL
pathways	NULL
.	NULL

This	NULL
synergy	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
is	NULL
capable	NULL
of	NULL
potentiating	NULL
biochemical	NULL
responses	NULL
,	NULL
at	NULL
least	NULL
in	NULL
terms	NULL
of	NULL
CREB	NULL
phosphorylation	NULL
.	NULL

Cross-talk	NULL
between	NULL
second	NULL
messengers	NULL
overcomes	NULL
individual	NULL
concentration	NULL
threshold	NULL
barriers	NULL
Although	NULL
our	NULL
present	NULL
data	NULL
demonstrate	NULL
the	NULL
requirement	NULL
for	NULL
synergistic	NULL
interactions	NULL
between	NULL
Ca	NULL
,	NULL
**	NULL
``	NULL
and	NULL
cAMP	NULL
to	NULL
facilitate	NULL
CD80	NULL
up-regulation	NULL
we	NULL
took	NULL
note	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
these	NULL
second	NULL
messengers	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
capable	NULL
of	NULL
independently	NULL
inducing	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
120	NULL
A	NULL
1020	NULL
3	NULL
40	NULL
5	NULL
60	NULL
7	NULL
8	NULL
i-	NULL
#	NULL
HW	NULL
ws	NULL
u	NULL
Go	NULL
ai	NULL
oh	NULL
usp	NULL
ND	NULL
U	NULL
C=	NULL
P.CREB	NULL
REGULATION	NULL
OF	NULL
CD80	NULL
AND	NULL
CD86	NULL
EXPRESSION	NULL
IN	NULL
B	NULL
CELLS	NULL
B	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
60	NULL
7	NULL
8	NULL
-	NULL
©	NULL
W	NULL
W	NULL
PCREB	NULL
U	NULL
W	NULL
UW	NULL
WU	NULL
W	NULL
w	NULL
-	NULL
«	NULL
-o	NULL
CREG	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
Ser'*	NULL
in	NULL
stimulated	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
,	NULL
Results	NULL
of	NULL
a	NULL
Western	NULL
blot	NULL
analysis	NULL
for	NULL
CREB	NULL
in	NULL
either	NULL
unstimulated	NULL
cells	NULL
(	NULL
Jane	NULL
1	NULL
)	NULL
or	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
with	NULL
anti-IgM	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
anti-CD54	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
(	NULL
Zane	NULL
4	NULL
)	NULL
.	NULL

Additional	NULL
sets	NULL
also	NULL
include	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
inhibitors	NULL
KN-62	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
Calphostin	NULL
C	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
,	NULL
H89	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
all	NULL
three	NULL
inhibitors	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
(	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Top	NULL
,	NULL
Results	NULL
obtained	NULL
using	NULL
Abs	NULL
specific	NULL
for	NULL
the	NULL
Ser'**-phosphorylated	NULL
form	NULL
of	NULL
CREB	NULL
(	NULL
P-CREB	NULL
)	NULL
.	NULL

Subsequent	NULL
to	NULL
this	NULL
,	NULL
bound	NULL
Abs	NULL
were	NULL
eluted	NULL
,	NULL
and	NULL
the	NULL
blots	NULL
were	NULL
probed	NULL
once	NULL
again	NULL
with	NULL
Abs	NULL
against	NULL
the	NULL
CREB	NULL
protein	NULL
(	NULL
bottom	NULL
,	NULL
CREB	NULL
)	NULL
.	NULL

B	NULL
,	NULL
Results	NULL
of	NULL
a	NULL
similar	NULL
experiment	NULL
except	NULL
that	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
0.5	NULL
uM	NULL
ionomycin	NULL
(	NULL
Jane	NULL
2	NULL
)	NULL
,	NULL
100	NULL
uM	NULL
db-cAMP	NULL
(	NULL
Zane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Results	NULL
for	NULL
parallel	NULL
sets	NULL
of	NULL
cells	NULL
stimulated	NULL
with	NULL
0.5	NULL
M	NULL
ionomycin	NULL
plus	NULL
100	NULL
M	NULL
db-cAMP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
KN-62	NULL
(	NULL
Zane	NULL
5	NULL
)	NULL
,	NULL
Calphostin	NULL
C	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
H89	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
all	NULL
three	NULL
inhibitors	NULL
(	NULL
Zane	NULL
8	NULL
)	NULL
.	NULL

Unstimulated	NULL
cells	NULL
are	NULL
represented	NULL
in	NULL
lane	NULL
1	NULL
.	NULL

Data	NULL
are	NULL
a	NULL
representative	NULL
of	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

CD80	NULL
expression	NULL
.	NULL

For	NULL
example	NULL
,	NULL
stimulation	NULL
of	NULL
B	NULL
lymphoma	NULL
cells	NULL
with	NULL
db-cAMP	NULL
alone	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
surface	NULL
CD80	NULL
expression	NULL
(	NULL
36	NULL
)	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
vein	NULL
,	NULL
stimulation	NULL
of	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
with	NULL
a	NULL
calcium	NULL
ionophore	NULL
has	NULL
also	NULL
been	NULL
found	NULL
to	NULL
result	NULL
in	NULL
CD80	NULL
up-regulation	NULL
(	NULL
47	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
both	NULL
cases	NULL
the	NULL
concentrations	NULL
of	NULL
stimulators	NULL
used	NULL
were	NULL
significantly	NULL
higher	NULL
than	NULL
those	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
36	NULL
,	NULL
47	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
occurred	NULL
to	NULL
us	NULL
that	NULL
the	NULL
cross-talk	NULL
between	NULL
Ca	NULL
,	NULL
;	NULL
**	NULL
and	NULL
cAMP	NULL
may	NULL
well	NULL
serve	NULL
to	NULL
minimize	NULL
individual	NULL
concentrations	NULL
required	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
CD80	NULL
expression	NULL
.	NULL

To	NULL
examine	NULL
for	NULL
such	NULL
a	NULL
possibility	NULL
,	NULL
purified	NULL
B	NULL
cells	NULL
were	NULL
independently	NULL
stimulated	NULL
with	NULL
varying	NULL
concentrations	NULL
of	NULL
either	NULL
ionomycin	NULL
or	NULL
db-cAMP	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
for	NULL
comparative	NULL
purposes	NULL
,	NULL
a	NULL
parallel	NULL
set	NULL
of	NULL
cells	NULL
was	NULL
also	NULL
stimulated	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
0.5	NULL
M	NULL
ionomycin	NULL
and	NULL
100	NULL
mM	NULL
db-cAMP	NULL
.	NULL

The	NULL
extent	NULL
of	NULL
surface	NULL
CD80	NULL
induction	NULL
in	NULL
each	NULL
of	NULL
these	NULL
cases	NULL
was	NULL
then	NULL
assessed	NULL
,	NULL
and	NULL
the	NULL
cumulative	NULL
results	NULL
are	NULL
presented	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

However	NULL
,	NULL
although	NULL
both	NULL
db-cAMP	NULL
and	NULL
ionomycin	NULL
were	NULL
independently	NULL
capable	NULL
of	NULL
producing	NULL
enhanced	NULL
CD80	NULL
expression	NULL
,	NULL
their	NULL
efficiency	NULL
was	NULL
poor	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Relatively	NULL
higher	NULL
concentrations	NULL
of	NULL
either	NULL
of	NULL
these	NULL
two	NULL
agents	NULL
were	NULL
required	NULL
to	NULL
produce	NULL
a	NULL
significant	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
this	NULL
,	NULL
the	NULL
combination	NULL
of	NULL
ionomycin	NULL
and	NULL
db-cAMP	NULL
proved	NULL
extremely	NULL
effective	NULL
,	NULL
yielding	NULL
optimal	NULL
CD80	NULL
enhancement	NULL
with	NULL
only	NULL
suboptimal	NULL
concentrations	NULL
of	NULL
the	NULL
individual	NULL
stimuli	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
results	NULL
reveal	NULL
that	NULL
the	NULL
concerted	NULL
action	NULL
of	NULL
second	NULL
messenger-dependent	NULL
signaling	NULL
modules	NULL
can	NULL
subvert	NULL
concentration	NULL
thresholds	NULL
80	NULL
70	NULL
so	NULL
%	NULL
(	NULL
4	NULL
40	NULL
30	NULL
20	NULL
10	NULL
``	NULL
°	NULL
o	NULL
~~	NULL
os	NULL
10	NULL
_-	NULL
20	NULL
``	NULL
50	NULL
db-c	NULL
AMP	NULL
L	NULL
--	NULL
--	NULL
L	NULL
--	NULL
--	NULL
A_	NULL
--	NULL
_L-p	NULL
__	NULL
(	NULL
FCM	NULL
)	NULL
0	NULL
_	NULL
100	NULL
200	NULL
300°	NULL
600	NULL
Relative	NULL
MFI	NULL
FIGURE	NULL
8	NULL
.	NULL

Thresholds	NULL
for	NULL
Ca	NULL
;	NULL
,	NULL
**	NULL
and	NULL
cAMP	NULL
for	NULL
induction	NULL
of	NULL
CD80	NULL
.	NULL

Purified	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
indicated	NULL
concentrations	NULL
of	NULL
either	NULL
ionomycin	NULL
(	NULL
Iono	NULL
,	NULL
O	NULL
)	NULL
or	NULL
db-cAMP	NULL
(	NULL
@	NULL
)	NULL
.	NULL

Following	NULL
this	NULL
,	NULL
the	NULL
subsequent	NULL
expression	NULL
of	NULL
surface	NULL
CD80	NULL
was	NULL
monitored	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
parallel	NULL
set	NULL
of	NULL
cells	NULL
was	NULL
also	NULL
treated	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
0.5	NULL
M	NULL
ionomycin	NULL
and	NULL
100	NULL
M	NULL
db-cAMP	NULL
for	NULL
comparative	NULL
purposes	NULL
.	NULL

The	NULL
resultant	NULL
enhancement	NULL
in	NULL
surface	NULL
CD80	NULL
expression	NULL
is	NULL
shown	NULL
by	NULL
the	NULL
open	NULL
column	NULL
.	NULL

Values	NULL
are	NULL
the	NULL
mean	NULL
(	NULL
+SD	NULL
)	NULL
of	NULL
five	NULL
separate	NULL
experiments	NULL
.	NULL

required	NULL
for	NULL
independent	NULL
action	NULL
,	NULL
at	NULL
least	NULL
in	NULL
the	NULL
context	NULL
of	NULL
CD80	NULL
regulation	NULL
.	NULL

Discussion	NULL
Although	NULL
studies	NULL
continue	NULL
to	NULL
detail	NULL
the	NULL
early	NULL
biochemical	NULL
events	NULL
initiated	NULL
upon	NULL
BCR	NULL
cross-linking	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
modulation	NULL
of	NULL
these	NULL
pathways	NULL
by	NULL
accessory	NULL
signals	NULL
is	NULL
also	NULL
being	NULL
increasingly	NULL
re-alized	NULL
.	NULL

One	NULL
way	NULL
of	NULL
viewing	NULL
the	NULL
signaling	NULL
cascades	NULL
,	NULL
initiated	NULL
upon	NULL
stimulation	NULL
of	NULL
a	NULL
given	NULL
cell	NULL
surface	NULL
molecule	NULL
,	NULL
can	NULL
be	NULL
as	NULL
analogous	NULL
to	NULL
the	NULL
wave	NULL
fronts	NULL
generated	NULL
upon	NULL
perturbation	NULL
at	NULL
a	NULL
single	NULL
source	NULL
.	NULL

In	NULL
such	NULL
a	NULL
case	NULL
,	NULL
the	NULL
interference	NULL
between	NULL
'wave-fronts	NULL
'	NULL
of	NULL
independent	NULL
origin	NULL
may	NULL
then	NULL
be	NULL
expected	NULL
to	NULL
lead	NULL
to	NULL
either	NULL
a	NULL
'constructive	NULL
'	NULL
or	NULL
``	NULL
destructive	NULL
``	NULL
outcome	NULL
.	NULL

A	NULL
good	NULL
example	NULL
of	NULL
the	NULL
former	NULL
is	NULL
the	NULL
coligation	NULL
of	NULL
BCR	NULL
with	NULL
the	NULL
CR2/CD19/TAP-1	NULL
complex	NULL
,	NULL
where	NULL
B	NULL
cell	NULL
responsiveness	NULL
is	NULL
heightened	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
crosslinking	NULL
of	NULL
BCR	NULL
with	NULL
the	NULL
FoyRIIb	NULL
coreceptor	NULL
,	NULL
where	NULL
B	NULL
cell	NULL
responsiveness	NULL
is	NULL
attenuated	NULL
(	NULL
17-20	NULL
)	NULL
,	NULL
may	NULL
be	NULL
considered	NULL
as	NULL
a	NULL
case	NULL
resulting	NULL
from	NULL
destructive	NULL
interference	NULL
.	NULL

Although	NULL
the	NULL
existence	NULL
of	NULL
signal	NULL
interference	NULL
is	NULL
now	NULL
well	NULL
estab-lished	NULL
,	NULL
our	NULL
understanding	NULL
of	NULL
the	NULL
various	NULL
modes	NULL
by	NULL
which	NULL
they	NULL
can	NULL
occur	NULL
is	NULL
sparse	NULL
.	NULL

It	NULL
was	NULL
with	NULL
the	NULL
intent	NULL
of	NULL
gaining	NULL
additional	NULL
insights	NULL
into	NULL
this	NULL
aspect	NULL
within	NULL
B	NULL
lymphocytes	NULL
that	NULL
this	NULL
study	NULL
was	NULL
under-taken	NULL
.	NULL

It	NULL
was	NULL
anticipated	NULL
that	NULL
our	NULL
present	NULL
experimental	NULL
system	NULL
,	NULL
using	NULL
anti-IgM	NULL
and	NULL
anti-€CD54	NULL
as	NULL
the	NULL
stimuli	NULL
,	NULL
would	NULL
shed	NULL
light	NULL
on	NULL
how	NULL
BCR-dependent	NULL
pathways	NULL
service	NULL
CD86	NULL
expression	NULL
on	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
and	NULL
concomitantly	NULL
integrate	NULL
with	NULL
CD54-dependent	NULL
pathways	NULL
to	NULL
modulate	NULL
CD80	NULL
levels	NULL
on	NULL
the	NULL
other	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
Ca	NULL
,	NULL
**	NULL
as	NULL
an	NULL
obligatory	NULL
mediator	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
both	NULL
CD80	NULL
and	NULL
CD86	NULL
provided	NULL
us	NULL
with	NULL
a	NULL
reference	NULL
point	NULL
for	NULL
further	NULL
study	NULL
.	NULL

This	NULL
was	NULL
particularly	NULL
true	NULL
given	NULL
that	NULL
this	NULL
intermediate	NULL
was	NULL
solely	NULL
a	NULL
product	NULL
of	NULL
BCR-triggering	NULL
,	NULL
where	NULL
the	NULL
second	NULL
phase	NULL
of	NULL
recruitment-by	NULL
capacitative	NULL
influx-proved	NULL
to	NULL
be	NULL
at	NULL
least	NULL
sufficient	NULL
to	NULL
account	NULL
for	NULL
the	NULL
effects	NULL
of	NULL
anti-IgM	NULL
.	NULL

It	NULL
was	NULL
at	NULL
this	NULL
stage	NULL
of	NULL
our	NULL
investigations	NULL
that	NULL
at	NULL
least	NULL
two	NULL
distinct	NULL
effector	NULL
modes	NULL
for	NULL
BCR-mobilized	NULL
Ca	NULL
,	NULL
**	NULL
had	NULL
become	NULL
apparent	NULL
.	NULL

On	NULL
the	NULL
one	NULL
hand	NULL
,	NULL
this	NULL
second	NULL
messenger	NULL
was	NULL
independently	NULL
capable	NULL
of	NULL
driving	NULL
CD86	NULL
up-regulation	NULL
.	NULL

Direct	NULL
evidence	NULL
in	NULL
support	NULL
of	NULL
such	NULL
a	NULL
conclusion	NULL
could	NULL
be	NULL
afforded	NULL
by	NULL
experiments	NULL
wherein	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
pretitrated	NULL
dose	NULL
of	NULL
ionomycin	NULL
proved	NULL
to	NULL
be	NULL
as	NULL
potent	NULL
as	NULL
anti-IgM	NULL
in	NULL
this	NULL
effect	NULL
.	NULL

However	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
this	NULL
,	NULL
BCR-dependent	NULL
Ca	NULL
,	NULL
``	NULL
was	NULL
also	NULL
shown	NULL
to	NULL
act	NULL
in	NULL
concert	NULL
with	NULL
CD54-driven	NULL
pathways	NULL
to	NULL
provide	NULL
for	NULL
an	NULL
amplified	NULL
cAMP	NULL
response	NULL
.	NULL

It	NULL
was	NULL
this	NULL
increased	NULL
accumulation	NULL
of	NULL
intracellular	NULL
cAMP	NULL
that	NULL
then	NULL
set	NULL
the	NULL
stage	NULL
for	NULL
a	NULL
second	NULL
round	NULL
of	NULL
cooperativity	NULL
between	NULL
Ca	NULL
;	NULL
,	NULL
**	NULL
``	NULL
and	NULL
cAMP	NULL
,	NULL
resulting	NULL
in	NULL
enhanced	NULL
surface	NULL
expression	NULL
of	NULL
CD80	NULL
.	NULL

The	NULL
direct	NULL
involvement	NULL
of	NULL
both	NULL
Ca	NULL
,	NULL
**	NULL
and	NULL
cAMP	NULL
in	NULL
the	NULL
latter	NULL
process	NULL
could	NULL
be	NULL
substantiated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
a	NULL
combination	NULL
of	NULL
ionomycin	NULL
and	NULL
db-cAMP	NULL
at	NULL
their	NULL
predefined	NULL
concentrations	NULL
was	NULL
as	NULL
effective	NULL
as	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
the	NULL
parent	NULL
stimulus	NULL
of	NULL
anti-IgM	NULL
plus	NULL
anti-€CD54	NULL
at	NULL
up-regulating	NULL
CD80	NULL
levels	NULL
.	NULL

The	NULL
interactions	NULL
between	NULL
BCR-mobilized	NULL
Ca	NULL
,	NULL
``	NULL
*-	NULL
and	NULL
CD54-dependent	NULL
signaling	NULL
pathways	NULL
could	NULL
also	NULL
be	NULL
evidenced	NULL
at	NULL
the	NULL
level	NULL
of	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
on	NULL
Ser'*	NULL
>	NULL
.	NULL

Although	NULL
a	NULL
role	NULL
for	NULL
CREB	NULL
in	NULL
CD80	NULL
regulation	NULL
is	NULL
yet	NULL
to	NULL
be	NULL
demonstrated	NULL
,	NULL
these	NULL
results	NULL
at	NULL
the	NULL
very	NULL
least	NULL
provide	NULL
biochemical	NULL
confirmation	NULL
for	NULL
the	NULL
productive	NULL
nature	NULL
of	NULL
this	NULL
interaction	NULL
.	NULL

Although	NULL
the	NULL
increase	NULL
in	NULL
Ser'*	NULL
>	NULL
phosphorylation	NULL
of	NULL
CREB	NULL
,	NULL
due	NULL
to	NULL
activation	NULL
of	NULL
cells	NULL
with	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
,	NULL
was	NULL
found	NULL
to	NULL
involve	NULL
kinase	NULL
intermediates	NULL
independently	NULL
recruited	NULL
by	NULL
the	NULL
individual	NULL
stimuli	NULL
,	NULL
the	NULL
observed	NULL
predominant	NULL
involvement	NULL
of	NULL
PKA	NULL
activity	NULL
is	NULL
intriguing	NULL
.	NULL

It	NULL
would	NULL
be	NULL
interesting	NULL
to	NULL
see	NULL
whether	NULL
the	NULL
potentiatory	NULL
effects	NULL
of	NULL
anti-IgM	NULL
plus	NULL
anti-CD54	NULL
stimulation	NULL
are	NULL
also	NULL
exercised	NULL
at	NULL
the	NULL
level	NULL
of	NULL
PKA	NULL
activation	NULL
.	NULL

Importantly	NULL
though	NULL
,	NULL
this	NULL
synergistic	NULL
effect	NULL
could	NULL
be	NULL
demonstrated	NULL
to	NULL
be	NULL
again	NULL
mediated	NULL
by	NULL
the	NULL
two	NULL
second	NULL
messengers	NULL
,	NULL
Ca	NULL
,	NULL
**	NULL
and	NULL
cAMP	NULL
,	NULL
providing	NULL
additional	NULL
evidence	NULL
for	NULL
a	NULL
constructive	NULL
interference	NULL
between	NULL
these	NULL
two	NULL
signaling	NULL
modules	NULL
.	NULL

It	NULL
has	NULL
been	NULL
previously	NULL
reported	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
that	NULL
enhancement	NULL
of	NULL
intracellular	NULL
cAMP	NULL
levels	NULL
before	NULL
BCR	NULL
ligation	NULL
has	NULL
inhibitory	NULL
effects	NULL
on	NULL
both	NULL
1,4,5-inositol	NULL
triphosphate	NULL
generation	NULL
and	NULL
Ca	NULL
,	NULL
**	NULL
mobilization	NULL
(	NULL
48	NULL
)	NULL
.	NULL

From	NULL
this	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
cross-talk	NULL
between	NULL
cAMP-	NULL
and	NULL
BCR-dependent	NULL
phosphoinositol	NULL
signaling	NULL
pathways	NULL
was	NULL
inferred	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Although	NULL
present	NULL
data	NULL
confirm	NULL
the	NULL
existence	NULL
of	NULL
such	NULL
a	NULL
cross-talk	NULL
,	NULL
they	NULL
also	NULL
suggest	NULL
that	NULL
the	NULL
outcome	NULL
of	NULL
this	NULL
process	NULL
is	NULL
strictly	NULL
dependent	NULL
upon	NULL
the	NULL
timing	NULL
at	NULL
which	NULL
these	NULL
two	NULL
pathways	NULL
are	NULL
initiated	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
attenuating	NULL
effects	NULL
of	NULL
sequential	NULL
triggering	NULL
,	NULL
simultaneous	NULL
initiation	NULL
leads	NULL
to	NULL
po-tentiation	NULL
of	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
subsequent	NULL
responses	NULL
.	NULL

However	NULL
,	NULL
the	NULL
biochemical	NULL
interactions	NULL
mediating	NULL
this	NULL
cross-talk	NULL
remain	NULL
un-known	NULL
,	NULL
and	NULL
would	NULL
clearly	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
delineate	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
above	NULL
,	NULL
our	NULL
present	NULL
characterization	NULL
of	NULL
the	NULL
interactions	NULL
between	NULL
BCR-	NULL
and	NULL
CD54-dependent	NULL
pathways	NULL
also	NULL
provides	NULL
a	NULL
novel	NULL
insight	NULL
into	NULL
the	NULL
networking	NULL
of	NULL
independently	NULL
generated	NULL
signaling	NULL
modules	NULL
.	NULL

As	NULL
the	NULL
data	NULL
suggests	NULL
,	NULL
this	NULL
constitutes	NULL
a	NULL
sequential	NULL
process	NULL
that	NULL
is	NULL
initiated	NULL
by	NULL
a	NULL
cross-talk	NULL
between	NULL
the	NULL
two	NULL
pathways	NULL
.	NULL

The	NULL
consequence	NULL
of	NULL
this	NULL
interaction	NULL
then	NULL
,	NULL
is	NULL
to	NULL
directly	NULL
promote	NULL
a	NULL
second	NULL
round	NULL
of	NULL
synergy	NULL
and	NULL
thereby	NULL
facilitate	NULL
CD80	NULL
up-regulation	NULL
.	NULL

In	NULL
other	NULL
words	NULL
,	NULL
these	NULL
findings	NULL
reveal	NULL
the	NULL
existence	NULL
of	NULL
``	NULL
dialectical	NULL
``	NULL
modes	NULL
of	NULL
signal	NULL
interference	NULL
,	NULL
which	NULL
can	NULL
contribute	NULL
toward	NULL
gain	NULL
of	NULL
function	NULL
for	NULL
the	NULL
target	NULL
cell	NULL
.	NULL

Finally	NULL
,	NULL
our	NULL
delineation	NULL
of	NULL
differences	NULL
in	NULL
both	NULL
the	NULL
concentration	NULL
and	NULL
spectrum	NULL
of	NULL
the	NULL
regulatory	NULL
intermediates	NULL
involved	NULL
during	NULL
expression	NULL
of	NULL
CD80	NULL
and	NULL
CD86	NULL
provides	NULL
an	NULL
empirical	NULL
explanation	NULL
for	NULL
their	NULL
distinct	NULL
induction	NULL
thresholds	NULL
.	NULL

Although	NULL
CD86	NULL
expression	NULL
could	NULL
be	NULL
achieved	NULL
through	NULL
a	NULL
relatively	NULL
moderate	NULL
augmentation	NULL
in	NULL
Ca	NULL
;	NULL
*	NULL
*	NULL
,	NULL
concomitant	NULL
induction	NULL
of	NULL
CD80	NULL
required	NULL
the	NULL
added	NULL
support	NULL
from	NULL
cAMP	NULL
recruitment	NULL
.	NULL

Our	NULL
observation	NULL
that	NULL
cross-talk	NULL
between	NULL
Ca-	NULL
and	NULL
cAMP	NULL
pathways	NULL
modulates	NULL
individual	NULL
concentrations	NULL
required	NULL
for	NULL
CD80	NULL
up-regulation	NULL
is	NULL
also	NULL
particularly	NULL
rele-vant	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
principle	NULL
,	NULL
either	NULL
independent	NULL
mobilization	NULL
of	NULL
any	NULL
of	NULL
these	NULL
mediators	NULL
at	NULL
optimal	NULL
concentrations	NULL
,	NULL
or	NULL
simultaneous	NULL
recruitment	NULL
of	NULL
both	NULL
at	NULL
suboptimal	NULL
concentrations	NULL
,	NULL
should	NULL
render	NULL
CD80	NULL
expression	NULL
permissive	NULL
at	NULL
least	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
,	NULL
then	NULL
,	NULL
that	NULL
the	NULL
versatility	NULL
offered	NULL
by	NULL
such	NULL
multiple	NULL
options	NULL
may	NULL
well	NULL
constitute	NULL
the	NULL
wherewithal	NULL
for	NULL
``	NULL
intelligent	NULL
decision-making	NULL
``	NULL
when	NULL
responding	NULL
to	NULL
external	NULL
stimuli	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Venkitaraman	NULL
,	NULL
A.	NULL
R.	NULL
,	NULL
G.	NULL
T.	NULL
Williams	NULL
,	NULL
P.	NULL
Dariavach	NULL
,	NULL
and	NULL
M.	NULL
S.	NULL
Neuberger	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
of	NULL
the	NULL
five	NULL
immunoglobulin	NULL
classes	NULL
.	NULL

Nature	NULL
352:777	NULL
.	NULL

2	NULL
.	NULL

Clark	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
K.	NULL
S.	NULL
Campbell	NULL
,	NULL
A.	NULL
Kazlauskas	NULL
,	NULL
S.	NULL
A.	NULL
Johnson	NULL
,	NULL
M.	NULL
Hertz	NULL
,	NULL
T.	NULL
A.	NULL
Potter	NULL
,	NULL
C.	NULL
Pleiman	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Cambier	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
complex	NULL
:	NULL
association	NULL
of	NULL
Ig-	NULL
@	NULL
and	NULL
Ig-	NULL
with	NULL
distinct	NULL
cytoplasmic	NULL
effectors	NULL
.	NULL

Science	NULL
258:123	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

121	NULL
.	NULL

Wienands	NULL
,	NULL
J.	NULL
,	NULL
O.	NULL
Larbolette	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Reth	NULL
.	NULL

1996	NULL
.	NULL

Evidence	NULL
for	NULL
a	NULL
preformed	NULL
transducer	NULL
complex	NULL
organized	NULL
by	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:7865.	NULL
.	NULL

DeFranco	NULL
,	NULL
A.	NULL
L.	NULL
1997	NULL
.	NULL

The	NULL
complexity	NULL
of	NULL
signaling	NULL
pathways	NULL
activated	NULL
by	NULL
BCR	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

9:296.	NULL
.	NULL

Campbell	NULL
,	NULL
K.	NULL
S.	NULL
1999	NULL
.	NULL

Signal	NULL
transduction	NULL
from	NULL
the	NULL
B	NULL
cell	NULL
receptor	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

11:256.	NULL
.	NULL

Kurosaki	NULL
,	NULL
T.	NULL
1999	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
signaling	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

17:593.	NULL
.	NULL

Mond	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
E.	NULL
Sehgal	NULL
,	NULL
J	NULL
.	NULL

King	NULL
,	NULL
and	NULL
F.	NULL
D.	NULL
Finkleman	NULL
.	NULL

1981	NULL
.	NULL

Increased	NULL
expression	NULL
of	NULL
T-region-associated	NULL
antigen	NULL
(	NULL
Ia	NULL
)	NULL
on	NULL
B	NULL
cells	NULL
after	NULL
crosslinking	NULL
of	NULL
surface	NULL
immu-noglobulin	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

127:881.	NULL
.	NULL

Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
and	NULL
E.	NULL
A.	NULL
Clarke	NULL
.	NULL

1994	NULL
.	NULL

How	NULL
B	NULL
and	NULL
T	NULL
cells	NULL
talk	NULL
to	NULL
each	NULL
other	NULL
.	NULL

Nature	NULL
367:425.	NULL
.	NULL

Armitage	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Anderson	NULL
.	NULL

1995	NULL
.	NULL

B	NULL
cell	NULL
stimulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

7:243	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
A.	NULL
I.	NULL
Sperling	NULL
,	NULL
M.	NULL
P.	NULL
Cooke	NULL
,	NULL
G.	NULL
Freeman	NULL
,	NULL
L.	NULL
Rhee	NULL
,	NULL
D.	NULL
C.	NULL
Decker	NULL
,	NULL
G.	NULL
Gray	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
C.	NULL
C.	NULL
Goodnow	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
upregulation	NULL
of	NULL
the	NULL
B7-1	NULL
and	NULL
B7-2	NULL
costimulatory	NULL
molecules	NULL
after	NULL
Ig	NULL
receptor	NULL
engagement	NULL
by	NULL
antigen	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:1990	NULL
.	NULL

Lahvis	NULL
,	NULL
G.	NULL
P.	NULL
,	NULL
and	NULL
J.	NULL
Cerny	NULL
.	NULL

1997	NULL
.	NULL

Induction	NULL
of	NULL
germinal	NULL
centre	NULL
B	NULL
cell	NULL
markers	NULL
in	NULL
vitro	NULL
by	NULL
activated	NULL
CD4*	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:1783	NULL
.	NULL

Goodnow	NULL
,	NULL
C.	NULL
C.	NULL
1996	NULL
.	NULL

Balancing	NULL
immunity	NULL
and	NULL
tolerance	NULL
;	NULL
deleting	NULL
and	NULL
tuning	NULL
lymphocyte	NULL
repertoires	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:2264	NULL
.	NULL

Goodnow	NULL
,	NULL
C.	NULL
C.	NULL
1997	NULL
.	NULL

Chance	NULL
encounters	NULL
and	NULL
organized	NULL
rendezvous	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

156:5	NULL
.	NULL

Fearon	NULL
,	NULL
D.	NULL
T.	NULL
1993	NULL
.	NULL

The	NULL
CD19-CR2-TAPA-1	NULL
complex	NULL
,	NULL
CD45	NULL
and	NULL
signaling	NULL
by	NULL
the	NULL
antigen	NULL
receptor	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

5:341	NULL
.	NULL

Carter	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
M.	NULL
O.	NULL
Spycher	NULL
,	NULL
Y.	NULL
C.	NULL
Ng	NULL
,	NULL
H.	NULL
Hoffman	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Fearon	NULL
.	NULL

1988	NULL
.	NULL

Synergistic	NULL
interactions	NULL
between	NULL
complement	NULL
receptor	NULL
type	NULL
2	NULL
and	NULL
membrane	NULL
IgM	NULL
on	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

141:457	NULL
.	NULL

Carter	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
D.	NULL
T.	NULL
Fearon	NULL
.	NULL

1992	NULL
.	NULL

Lowering	NULL
the	NULL
threshold	NULL
for	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Science	NULL
256:105	NULL
.	NULL

Phillips	NULL
,	NULL
N.	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
C.	NULL
Parker	NULL
.	NULL

1983	NULL
.	NULL

Fc-Dependent	NULL
inhibition	NULL
of	NULL
mouse	NULL
B	NULL
cell	NULL
activation	NULL
by	NULL
whole	NULL
anti-u	NULL
antibodies	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

130:602	NULL
.	NULL

Bijsterbosch	NULL
,	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
G.	NULL
B.	NULL
Klaus	NULL
.	NULL

Crosslinking	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
and	NULL
Fc	NULL
receptor	NULL
on	NULL
B	NULL
lymphocytes	NULL
inhibits	NULL
stimulation	NULL
of	NULL
inositol	NULL
phospholipid	NULL
breakdown	NULL
via	NULL
the	NULL
antigen	NULL
receptor	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

162:1825	NULL
.	NULL

Choquet	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Partiseti	NULL
,	NULL
S.	NULL
Amigorena	NULL
,	NULL
C.	NULL
Bonnerot	NULL
,	NULL
W.	NULL
H.	NULL
Fridman	NULL
,	NULL
and	NULL
H.	NULL
Korn	NULL
.	NULL

1993	NULL
.	NULL

Crosslinking	NULL
of	NULL
IgG	NULL
receptor	NULL
inhibits	NULL
membrane	NULL
immunoglobulin	NULL
stimulated	NULL
calcium	NULL
influx	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

121:355	NULL
.	NULL

Hipper	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
P.	NULL
Buhl	NULL
,	NULL
D.	NULL
D'Ambrosio	NULL
,	NULL
K.	NULL
Nakamura	NULL
,	NULL
C.	NULL
Persin	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Cambier	NULL
.	NULL

1997	NULL
.	NULL

FeyRIIB1	NULL
inhibition	NULL
of	NULL
BCR-mediated	NULL
phosphoinositide	NULL
hydrolysis	NULL
and	NULL
Ca**	NULL
mobilization	NULL
is	NULL
integrated	NULL
by	NULL
CD19	NULL
dephosphorylation	NULL
.	NULL

Immunity	NULL
7:49	NULL
.	NULL

Bobbit	NULL
,	NULL
K.	NULL
R.	NULL
,	NULL
and	NULL
L.	NULL
B.	NULL
Justement	NULL
.	NULL

2000	NULL
.	NULL

Regulation	NULL
of	NULL
MHC	NULL
class	NULL
II	NULL
signal	NULL
transduction	NULL
by	NULL
the	NULL
B	NULL
cell	NULL
coreceptors	NULL
CD19	NULL
and	NULL
CD22	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:5588	NULL
.	NULL

Vijayakrishnan	NULL
,	NULL
L.	NULL
,	NULL
K.	NULL
Natarajan	NULL
,	NULL
V.	NULL
Manivel	NULL
,	NULL
S.	NULL
Raisuddin	NULL
,	NULL
and	NULL
K.	NULL
V.	NULL
S.	NULL
Rao	NULL
.	NULL

2000	NULL
.	NULL

B	NULL
cell	NULL
responses	NULL
to	NULL
a	NULL
peptide	NULL
epitope	NULL
.	NULL

IX	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
antigen	NULL
binding	NULL
differentially	NULL
regulates	NULL
costimulatory	NULL
capacity	NULL
of	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

164:5605	NULL
.	NULL

Lenschow	NULL
,	NULL
D.	NULL
J.	NULL
,	NULL
T.	NULL
L.	NULL
Walunas	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Bluestone	NULL
.	NULL

1996	NULL
.	NULL

CD28/B7	NULL
system	NULL
of	NULL
T	NULL
cell	NULL
costimulation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:223	NULL
.	NULL

Galibert	NULL
,	NULL
L.	NULL
,	NULL
N.	NULL
Burdin	NULL
,	NULL
B.	NULL
de	NULL
Saint-Vis	NULL
,	NULL
P.	NULL
Garrone	NULL
,	NULL
C.	NULL
V.	NULL
Kooten	NULL
,	NULL
J.	NULL
Bancherau	NULL
,	NULL
and	NULL
F.	NULL
Rousset	NULL
.	NULL

1996	NULL
.	NULL

CD40	NULL
and	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
dual	NULL
triggering	NULL
of	NULL
resting	NULL
B	NULL
lymphocytes	NULL
turns	NULL
on	NULL
a	NULL
partial	NULL
germinal	NULL
center	NULL
phenotype	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:77	NULL
.	NULL

Harlow	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
D.	NULL
Lane	NULL
.	NULL

1988	NULL
.	NULL

Antibodies	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
,	NULL
p.	NULL
630	NULL
.	NULL

Akiyama	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
H.	NULL
Ogawa	NULL
.	NULL

1991	NULL
.	NULL

Use	NULL
and	NULL
specificity	NULL
of	NULL
genistein	NULL
as	NULL
an	NULL
inhibitor	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Methods	NULL
Enzymol	NULL
.	NULL

201:360	NULL
.	NULL

Kubohara	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
K.	NULL
Hosaka	NULL
.	NULL

1999	NULL
.	NULL

The	NULL
putative	NULL
morphogen	NULL
,	NULL
DIF-1	NULL
,	NULL
of	NULL
Dictyo-stelium	NULL
discoideum	NULL
activates	NULL
Akt/PKB	NULL
in	NULL
human	NULL
leukemia	NULL
K562	NULL
cells	NULL
.	NULL

Biochem	NULL
.	NULL

Biophys	NULL
.	NULL

Res	NULL
.	NULL

Comm	NULL
.	NULL

263:790	NULL
.	NULL

Dolmetsch	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
K.	NULL
Xu	NULL
,	NULL
and	NULL
R.	NULL
S.	NULL
Lewis	NULL
.	NULL

1998	NULL
.	NULL

Calcium	NULL
oscillations	NULL
increase	NULL
the	NULL
efficiency	NULL
and	NULL
specificity	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Nature	NULL
392:932	NULL
.	NULL

Cambier	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Ransom	NULL
.	NULL

1987	NULL
.	NULL

Molecular	NULL
mechanisms	NULL
of	NULL
transmem-brane	NULL
signals	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

5:175	NULL
.	NULL

Gelfard	NULL
,	NULL
E.	NULL
W.	NULL
,	NULL
S.	NULL
L.	NULL
MacDougall	NULL
,	NULL
R.	NULL
K.	NULL
Cheung	NULL
,	NULL
and	NULL
S.	NULL
Grinstein	NULL
.	NULL

1989	NULL
.	NULL

Independent	NULL
regulation	NULL
of	NULL
Ca®*	NULL
entry	NULL
and	NULL
release	NULL
from	NULL
internal	NULL
stores	NULL
in	NULL
activated	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170:315	NULL
.	NULL

Penner	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Fasoloto	NULL
,	NULL
and	NULL
M.	NULL
Hoth	NULL
.	NULL

1993	NULL
.	NULL

Calcium	NULL
influx	NULL
and	NULL
its	NULL
control	NULL
by	NULL
calcium	NULL
release	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Neurobiol	NULL
.	NULL

3:368	NULL
.	NULL

Van	NULL
Horssen	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
Loman	NULL
,	NULL
G.	NULL
T.	NULL
Rijkers	NULL
,	NULL
S.	NULL
E.	NULL
Boom	NULL
,	NULL
and	NULL
A.	NULL
C.	NULL
Bloem	NULL
.	NULL

1995	NULL
.	NULL

Co-ligation	NULL
of	NULL
ICAM-1	NULL
(	NULL
CD54	NULL
)	NULL
and	NULL
membrane	NULL
IgM	NULL
negatively	NULL
affects	NULL
B	NULL
cell	NULL
receptor	NULL
signaling	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25:154	NULL
.	NULL

Etienne-Manneville	NULL
,	NULL
S.	NULL
,	NULL
J.-B	NULL
.	NULL

Manneville	NULL
,	NULL
P.	NULL
Adamson	NULL
,	NULL
B.	NULL
Wilboum	NULL
,	NULL
J.	NULL
Greenwood	NULL
,	NULL
and	NULL
P.-D.	NULL
Couraud	NULL
.	NULL

2000	NULL
.	NULL

ICAM-1	NULL
coupled	NULL
cytoskeletal	NULL
rearrangement	NULL
and	NULL
transendothelial	NULL
lymphocyte	NULL
migration	NULL
involve	NULL
intracellular	NULL
calcium	NULL
signaling	NULL
in	NULL
brain	NULL
endothelial	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

165:3375	NULL
.	NULL

Dolmetsch	NULL
,	NULL
R.	NULL
E.	NULL
,	NULL
R.	NULL
S.	NULL
Lewis	NULL
,	NULL
C.	NULL
C.	NULL
Goodnow	NULL
,	NULL
and	NULL
J.	NULL
I.	NULL
Healy	NULL
.	NULL

1997	NULL
.	NULL

Differential	NULL
activation	NULL
of	NULL
transcription	NULL
factors	NULL
induced	NULL
by	NULL
Ca**	NULL
response	NULL
amplitude	NULL
and	NULL
du-ration	NULL
.	NULL

Nature	NULL
386:855	NULL
.	NULL

Benschop	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
D.	NULL
Melamed	NULL
,	NULL
D.	NULL
Nemazee	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Cambier	NULL
.	NULL

1999	NULL
.	NULL

Distinct	NULL
signal	NULL
thresholds	NULL
for	NULL
the	NULL
unique	NULL
antigen	NULL
receptor-linked	NULL
gene	NULL
expression	NULL
programs	NULL
in	NULL
mature	NULL
and	NULL
immature	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

190:749	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
122	NULL
36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Nabavi	NULL
,	NULL
N.	NULL
,	NULL
G.	NULL
J.	NULL
Freeman	NULL
,	NULL
A.	NULL
Gault	NULL
,	NULL
D.	NULL
Godfrey	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
and	NULL
L.	NULL
H.	NULL
Glimcher	NULL
.	NULL

1992	NULL
.	NULL

Signaling	NULL
through	NULL
the	NULL
MHC	NULL
class	NULL
II	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
antigen	NULL
presentation	NULL
and	NULL
inducing	NULL
B7	NULL
expression	NULL
.	NULL

Nature	NULL
360:266	NULL
.	NULL

Etienne-Manneville	NULL
,	NULL
S.	NULL
,	NULL
N.	NULL
Chaverot	NULL
,	NULL
A.	NULL
D.	NULL
Strosberg	NULL
,	NULL
and	NULL
P.-D.	NULL
Couraud	NULL
.	NULL

1999	NULL
.	NULL

ICAM-1-coupled	NULL
signaling	NULL
pathways	NULL
in	NULL
astrocytes	NULL
converge	NULL
to	NULL
cyclic	NULL
AMP	NULL
response	NULL
element-binding	NULL
protein	NULL
phosphorylation	NULL
and	NULL
TNF-a	NULL
secretion	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163:668	NULL
.	NULL

Xie	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Rothstein	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
kinase	NULL
C	NULL
mediates	NULL
activation	NULL
of	NULL
nuclear	NULL
cAMP	NULL
response	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
in	NULL
B	NULL
lymphocytes	NULL
stimulated	NULL
through	NULL
surface	NULL
Ig	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:1717	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
K.	NULL
,	NULL
G.	NULL
A.	NULL
Gonzalez	NULL
,	NULL
W.	NULL
H.	NULL
Biggs	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Montminy	NULL
.	NULL

1988	NULL
.	NULL

Phosphorylation-induced	NULL
binding	NULL
ad	NULL
transcriptional	NULL
efficacy	NULL
of	NULL
nuclear	NULL
factor	NULL
CREB	NULL
.	NULL

Nature	NULL
334:494	NULL
.	NULL

Alberts	NULL
,	NULL
A.	NULL
,	NULL
J.	NULL
Arias	NULL
,	NULL
M.	NULL
Hagiwara	NULL
,	NULL
M.	NULL
Montminy	NULL
,	NULL
and	NULL
J.	NULL
Feramiso	NULL
.	NULL

1994	NULL
.	NULL

Re-combinant	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
phosphorylation	NULL
on	NULL
Ser-133	NULL
is	NULL
transcriptionally	NULL
activated	NULL
upon	NULL
its	NULL
introduction	NULL
into	NULL
fibroblast	NULL
nuclei	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:7623	NULL
.	NULL

Corton	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
J.	NULL
G.	NULL
Gillespe	NULL
,	NULL
and	NULL
D.	NULL
G.	NULL
Hardie	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
AMP-activated	NULL
protein	NULL
kinase	NULL
in	NULL
the	NULL
cellular	NULL
stress	NULL
response	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

4:315	NULL
.	NULL

De	NULL
Rooij	NULL
,	NULL
J.	NULL
,	NULL
F.	NULL
J.	NULL
T.	NULL
Zwartkruis	NULL
,	NULL
M.	NULL
H.	NULL
G.	NULL
Verteijen	NULL
,	NULL
R.	NULL
H.	NULL
Cool	NULL
,	NULL
S.	NULL
B.	NULL
M.	NULL
Nijman	NULL
,	NULL
A.	NULL
Wittinghofer	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Bos	NULL
.	NULL

1998	NULL
.	NULL

Epac	NULL
is	NULL
a	NULL
Rapl	NULL
guanine-nucleotide-ex-change	NULL
factor	NULL
activated	NULL
by	NULL
cyclic	NULL
AMP	NULL
.	NULL

Nature	NULL
396:474	NULL
.	NULL

Whisler	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
L.	NULL
Beiquing	NULL
,	NULL
I.	NULL
S.	NULL
Grants	NULL
,	NULL
and	NULL
Y.	NULL
G.	NULL
Newhouse	NULL
.	NULL

1992	NULL
.	NULL

Cyclic	NULL
AMP	NULL
modulation	NULL
of	NULL
human	NULL
B	NULL
cell	NULL
proliferative	NULL
responses	NULL
:	NULL
role	NULL
of	NULL
cAMP-dependent	NULL
45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

REGULATION	NULL
OF	NULL
CD80	NULL
AND	NULL
CD86	NULL
EXPRESSION	NULL
IN	NULL
B	NULL
CELLS	NULL
protein	NULL
kinase	NULL
in	NULL
enhancing	NULL
cell	NULL
responses	NULL
to	NULL
phorbol	NULL
diesters	NULL
and	NULL
ionomycin	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

142:398.	NULL
.	NULL

Tohda	NULL
,	NULL
M.	NULL
,	NULL
J.	NULL
Nakamura	NULL
.	NULL

H.	NULL
Hidaki	NULL
,	NULL
and	NULL
Y.	NULL
Nomura	NULL
.	NULL

1991	NULL
.	NULL

Inhibitory	NULL
effects	NULL
of	NULL
KN-62	NULL
,	NULL
a	NULL
specific	NULL
inhibitor	NULL
of	NULL
Ca/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
,	NULL
on	NULL
serotonin-evoked	NULL
C1~	NULL
current	NULL
and	NULL
*°CI~	NULL
efflux	NULL
in	NULL
xenopus	NULL
oocytes	NULL
.	NULL

Neurosci	NULL
.	NULL

Lett	NULL
.	NULL

129:147	NULL
.	NULL

Hidaka	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
H.	NULL
Yokokura	NULL
.	NULL

1996	NULL
.	NULL

Molecular	NULL
and	NULL
cellular	NULL
pharmacology	NULL
of	NULL
a	NULL
calcium/calmodulin-dependent	NULL
protein	NULL
kinase	NULL
II	NULL
(	NULL
CaM	NULL
Kinase	NULL
II	NULL
)	NULL
inhibitor	NULL
,	NULL
KN62	NULL
,	NULL
and	NULL
a	NULL
proposal	NULL
of	NULL
CaM	NULL
Kinase	NULL
phosphorylation	NULL
cascades	NULL
.	NULL

In	NULL
Intracellular	NULL
Signal	NULL
Transduction	NULL
.	NULL

H.	NULL
Hidaka	NULL
and	NULL
A.	NULL
C.	NULL
Nairn	NULL
,	NULL
eds	NULL
.	NULL

Academic	NULL
Press	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
.	NULL

p.	NULL
193	NULL
.	NULL

Cambier	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Z	NULL
.	NULL

Z.	NULL
Chen	NULL
,	NULL
J.	NULL
Pasternak	NULL
,	NULL
J	NULL
.	NULL

Ransom	NULL
,	NULL
V.	NULL
Sandoral	NULL
,	NULL
and	NULL
H.	NULL
Pickles	NULL
.	NULL

1998	NULL
.	NULL

Ligand	NULL
induced	NULL
desensitization	NULL
of	NULL
B	NULL
cell	NULL
membrane	NULL
immunoglobulin-me-diated	NULL
Ca	NULL
``	NULL
mobilization	NULL
ad	NULL
protein	NULL
kinase	NULL
C	NULL
translocation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:6493	NULL
.	NULL

Engels	NULL
,	NULL
F.	NULL
H.	NULL
C.	NULL
,	NULL
G.	NULL
K.	NULL
Koshi	NULL
,	NULL
I.	NULL
Bedrosian	NULL
,	NULL
S.	NULL
Xu	NULL
,	NULL
S.	NULL
Luger	NULL
,	NULL
P.	NULL
C.	NULL
Nowell	NULL
,	NULL
P.	NULL
A.	NULL
Cohen	NULL
,	NULL
and	NULL
B.	NULL
S.	NULL
Czerniecki	NULL
.	NULL

1999	NULL
.	NULL

Calcium	NULL
signaling	NULL
induces	NULL
acquisition	NULL
of	NULL
dendritic	NULL
cell	NULL
characterization	NULL
in	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
myeloid	NULL
progenitor	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96:10332	NULL
.	NULL

Muthuswamy	NULL
,	NULL
N.	NULL
,	NULL
A.	NULL
R.	NULL
Baluyut	NULL
,	NULL
and	NULL
B.	NULL
Subbarao	NULL
.	NULL

1991	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
surface	NULL
Ig-	NULL
and	NULL
Lyb2-mediated	NULL
B	NULL
cell	NULL
activation	NULL
by	NULL
cyclic	NULL
AMP	NULL
.	NULL

I	NULL
.	NULL

Evidence	NULL
for	NULL
alternative	NULL
regulation	NULL
of	NULL
signaling	NULL
through	NULL
two	NULL
different	NULL
receptors	NULL
linked	NULL
to	NULL
phosphoinositol	NULL
hydrolysis	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:2483	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

